SI7511368A8 - Process for obtaining 2,4,6-nitriiodo-5-(2,4,6-triiodo-5-amino-benzoyl)-amino-alkyl- carbonyl-amino-benzoic acids - Google Patents
Process for obtaining 2,4,6-nitriiodo-5-(2,4,6-triiodo-5-amino-benzoyl)-amino-alkyl- carbonyl-amino-benzoic acids Download PDFInfo
- Publication number
- SI7511368A8 SI7511368A8 SI7511368A SI7511368A SI7511368A8 SI 7511368 A8 SI7511368 A8 SI 7511368A8 SI 7511368 A SI7511368 A SI 7511368A SI 7511368 A SI7511368 A SI 7511368A SI 7511368 A8 SI7511368 A8 SI 7511368A8
- Authority
- SI
- Slovenia
- Prior art keywords
- compound
- triiodo
- methyl
- amino
- benzoic acid
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 29
- 238000002360 preparation method Methods 0.000 claims description 91
- 150000001412 amines Chemical class 0.000 claims description 59
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 claims description 54
- 239000002253 acid Substances 0.000 claims description 37
- 229910052739 hydrogen Inorganic materials 0.000 claims description 21
- 239000001257 hydrogen Substances 0.000 claims description 20
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 20
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 16
- -1 2,4,6-triiodo-5-amino-benzoyl Chemical group 0.000 claims description 14
- 238000006243 chemical reaction Methods 0.000 claims description 14
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical group CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 12
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical group CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 9
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 5
- 229960004050 aminobenzoic acid Drugs 0.000 claims description 5
- 239000002798 polar solvent Substances 0.000 claims description 5
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 2
- 239000005711 Benzoic acid Substances 0.000 description 122
- 239000000047 product Substances 0.000 description 121
- 150000001875 compounds Chemical class 0.000 description 90
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 50
- 239000003480 eluent Substances 0.000 description 50
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 43
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 40
- 229940125904 compound 1 Drugs 0.000 description 40
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 32
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 30
- 125000006367 bivalent amino carbonyl group Chemical group [H]N([*:1])C([*:2])=O 0.000 description 30
- 230000003749 cleanliness Effects 0.000 description 25
- 239000000243 solution Substances 0.000 description 25
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 24
- 239000011630 iodine Substances 0.000 description 24
- 229910052740 iodine Inorganic materials 0.000 description 24
- 229910000029 sodium carbonate Inorganic materials 0.000 description 20
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 18
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 17
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 17
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 15
- 238000001035 drying Methods 0.000 description 15
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 14
- 230000021736 acetylation Effects 0.000 description 14
- 238000006640 acetylation reaction Methods 0.000 description 14
- 238000009833 condensation Methods 0.000 description 13
- 230000005494 condensation Effects 0.000 description 13
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
- 238000003756 stirring Methods 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 11
- 238000005406 washing Methods 0.000 description 9
- QCMHGCDOZLWPOT-FMNCTDSISA-N COC1=C(CC[C@@H]2CCC3=C(C2)C=CC(=C3)[C@H]2CC[C@](N)(CO)C2)C=CC=C1 Chemical compound COC1=C(CC[C@@H]2CCC3=C(C2)C=CC(=C3)[C@H]2CC[C@](N)(CO)C2)C=CC=C1 QCMHGCDOZLWPOT-FMNCTDSISA-N 0.000 description 8
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 8
- 239000007859 condensation product Substances 0.000 description 8
- 239000002244 precipitate Substances 0.000 description 8
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 7
- 229910021529 ammonia Inorganic materials 0.000 description 7
- 238000000746 purification Methods 0.000 description 7
- 150000003254 radicals Chemical class 0.000 description 7
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 6
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 6
- 239000000460 chlorine Substances 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 239000012043 crude product Substances 0.000 description 6
- 238000002425 crystallisation Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 6
- 238000007127 saponification reaction Methods 0.000 description 6
- 239000007858 starting material Substances 0.000 description 6
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 5
- 230000002378 acidificating effect Effects 0.000 description 5
- 239000003610 charcoal Substances 0.000 description 5
- 229910052801 chlorine Inorganic materials 0.000 description 5
- 230000008025 crystallization Effects 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- ABJSOROVZZKJGI-OCYUSGCXSA-N (1r,2r,4r)-2-(4-bromophenyl)-n-[(4-chlorophenyl)-(2-fluoropyridin-4-yl)methyl]-4-morpholin-4-ylcyclohexane-1-carboxamide Chemical compound C1=NC(F)=CC(C(NC(=O)[C@H]2[C@@H](C[C@@H](CC2)N2CCOCC2)C=2C=CC(Br)=CC=2)C=2C=CC(Cl)=CC=2)=C1 ABJSOROVZZKJGI-OCYUSGCXSA-N 0.000 description 4
- FANCTJAFZSYTIS-IQUVVAJASA-N (1r,3s,5z)-5-[(2e)-2-[(1r,3as,7ar)-7a-methyl-1-[(2r)-4-(phenylsulfonimidoyl)butan-2-yl]-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol Chemical compound C([C@@H](C)[C@@H]1[C@]2(CCCC(/[C@@H]2CC1)=C\C=C\1C([C@@H](O)C[C@H](O)C/1)=C)C)CS(=N)(=O)C1=CC=CC=C1 FANCTJAFZSYTIS-IQUVVAJASA-N 0.000 description 4
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 4
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Natural products CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 4
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 229940126543 compound 14 Drugs 0.000 description 4
- 239000002872 contrast media Substances 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 230000008020 evaporation Effects 0.000 description 4
- 238000006698 hydrazinolysis reaction Methods 0.000 description 4
- 150000002430 hydrocarbons Chemical class 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 3
- DRSHXJFUUPIBHX-UHFFFAOYSA-N COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 Chemical compound COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 DRSHXJFUUPIBHX-UHFFFAOYSA-N 0.000 description 3
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 3
- 241000282326 Felis catus Species 0.000 description 3
- 238000001321 HNCO Methods 0.000 description 3
- OWIKHYCFFJSOEH-UHFFFAOYSA-N Isocyanic acid Chemical compound N=C=O OWIKHYCFFJSOEH-UHFFFAOYSA-N 0.000 description 3
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 3
- 239000000370 acceptor Substances 0.000 description 3
- 150000003863 ammonium salts Chemical class 0.000 description 3
- OSVHLUXLWQLPIY-KBAYOESNSA-N butyl 2-[(6aR,9R,10aR)-1-hydroxy-9-(hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-3-yl]-2-methylpropanoate Chemical compound C(CCC)OC(C(C)(C)C1=CC(=C2[C@H]3[C@H](C(OC2=C1)(C)C)CC[C@H](C3)CO)O)=O OSVHLUXLWQLPIY-KBAYOESNSA-N 0.000 description 3
- 229940125797 compound 12 Drugs 0.000 description 3
- 229940125782 compound 2 Drugs 0.000 description 3
- 229940126214 compound 3 Drugs 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 210000001105 femoral artery Anatomy 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000011987 methylation Effects 0.000 description 3
- 238000007069 methylation reaction Methods 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- ASGMFNBUXDJWJJ-JLCFBVMHSA-N (1R,3R)-3-[[3-bromo-1-[4-(5-methyl-1,3,4-thiadiazol-2-yl)phenyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]-N,1-dimethylcyclopentane-1-carboxamide Chemical compound BrC1=NN(C2=NC(=NC=C21)N[C@H]1C[C@@](CC1)(C(=O)NC)C)C1=CC=C(C=C1)C=1SC(=NN=1)C ASGMFNBUXDJWJJ-JLCFBVMHSA-N 0.000 description 2
- UAOUIVVJBYDFKD-XKCDOFEDSA-N (1R,9R,10S,11R,12R,15S,18S,21R)-10,11,21-trihydroxy-8,8-dimethyl-14-methylidene-4-(prop-2-enylamino)-20-oxa-5-thia-3-azahexacyclo[9.7.2.112,15.01,9.02,6.012,18]henicosa-2(6),3-dien-13-one Chemical compound C([C@@H]1[C@@H](O)[C@@]23C(C1=C)=O)C[C@H]2[C@]12C(N=C(NCC=C)S4)=C4CC(C)(C)[C@H]1[C@H](O)[C@]3(O)OC2 UAOUIVVJBYDFKD-XKCDOFEDSA-N 0.000 description 2
- GLGNXYJARSMNGJ-VKTIVEEGSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound CCN1C(=O)CCCC2=C(OC)C(NC=3N=C(C(=CN=3)Cl)N[C@H]3[C@H]([C@@]4([H])C[C@@]3(C=C4)[H])C(N)=O)=CC=C21 GLGNXYJARSMNGJ-VKTIVEEGSA-N 0.000 description 2
- SAGQGRMEBBBUCA-IXCHPVQKSA-N (2S,3S,4R,5R)-2,3,4,5-tetraacetyl-2,3,4,5,6-pentahydroxy-7-oxooctanoyl chloride Chemical compound C(C)(=O)C([C@]([C@]([C@@]([C@](C(=O)Cl)(O)C(C)=O)(O)C(C)=O)(O)C(C)=O)(O)C(C)=O)O SAGQGRMEBBBUCA-IXCHPVQKSA-N 0.000 description 2
- LJIOTBMDLVHTBO-CUYJMHBOSA-N (2s)-2-amino-n-[(1r,2r)-1-cyano-2-[4-[4-(4-methylpiperazin-1-yl)sulfonylphenyl]phenyl]cyclopropyl]butanamide Chemical compound CC[C@H](N)C(=O)N[C@]1(C#N)C[C@@H]1C1=CC=C(C=2C=CC(=CC=2)S(=O)(=O)N2CCN(C)CC2)C=C1 LJIOTBMDLVHTBO-CUYJMHBOSA-N 0.000 description 2
- TWYYFYNJOJGNFP-CUXYNZQBSA-N (2s,4r,5s,6s)-2-[(4s,5r)-4-acetyloxy-5-methyl-3-methylidene-6-phenylhexyl]-2-carbamoyl-4-[[(e,4s,6s)-4,6-dimethyloct-2-enoyl]oxymethyl]-5-hydroxy-1,3-dioxane-4,5,6-tricarboxylic acid Chemical compound O1[C@H](C(O)=O)[C@](C(O)=O)(O)[C@](COC(=O)/C=C/[C@@H](C)C[C@@H](C)CC)(C(O)=O)O[C@]1(C(N)=O)CCC(=C)[C@@H](OC(C)=O)[C@H](C)CC1=CC=CC=C1 TWYYFYNJOJGNFP-CUXYNZQBSA-N 0.000 description 2
- UDQTXCHQKHIQMH-KYGLGHNPSA-N (3ar,5s,6s,7r,7ar)-5-(difluoromethyl)-2-(ethylamino)-5,6,7,7a-tetrahydro-3ah-pyrano[3,2-d][1,3]thiazole-6,7-diol Chemical compound S1C(NCC)=N[C@H]2[C@@H]1O[C@H](C(F)F)[C@@H](O)[C@@H]2O UDQTXCHQKHIQMH-KYGLGHNPSA-N 0.000 description 2
- YQOLEILXOBUDMU-KRWDZBQOSA-N (4R)-5-[(6-bromo-3-methyl-2-pyrrolidin-1-ylquinoline-4-carbonyl)amino]-4-(2-chlorophenyl)pentanoic acid Chemical compound CC1=C(C2=C(C=CC(=C2)Br)N=C1N3CCCC3)C(=O)NC[C@H](CCC(=O)O)C4=CC=CC=C4Cl YQOLEILXOBUDMU-KRWDZBQOSA-N 0.000 description 2
- VUDZSIYXZUYWSC-DBRKOABJSA-N (4r)-1-[(2r,4r,5r)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1,3-diazinan-2-one Chemical compound FC1(F)[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)N[C@H](O)CC1 VUDZSIYXZUYWSC-DBRKOABJSA-N 0.000 description 2
- VIMMECPCYZXUCI-MIMFYIINSA-N (4s,6r)-6-[(1e)-4,4-bis(4-fluorophenyl)-3-(1-methyltetrazol-5-yl)buta-1,3-dienyl]-4-hydroxyoxan-2-one Chemical compound CN1N=NN=C1C(\C=C\[C@@H]1OC(=O)C[C@@H](O)C1)=C(C=1C=CC(F)=CC=1)C1=CC=C(F)C=C1 VIMMECPCYZXUCI-MIMFYIINSA-N 0.000 description 2
- JHLIGYPHPBLDDL-UHFFFAOYSA-N (5-pyridin-3-ylthiophen-2-yl)methanamine Chemical compound S1C(CN)=CC=C1C1=CC=CN=C1 JHLIGYPHPBLDDL-UHFFFAOYSA-N 0.000 description 2
- IGVKWAAPMVVTFX-BUHFOSPRSA-N (e)-octadec-5-en-7,9-diynoic acid Chemical compound CCCCCCCCC#CC#C\C=C\CCCC(O)=O IGVKWAAPMVVTFX-BUHFOSPRSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 2
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 2
- FQMZXMVHHKXGTM-UHFFFAOYSA-N 2-(1-adamantyl)-n-[2-[2-(2-hydroxyethylamino)ethylamino]quinolin-5-yl]acetamide Chemical compound C1C(C2)CC(C3)CC2CC13CC(=O)NC1=CC=CC2=NC(NCCNCCO)=CC=C21 FQMZXMVHHKXGTM-UHFFFAOYSA-N 0.000 description 2
- YSUIQYOGTINQIN-UZFYAQMZSA-N 2-amino-9-[(1S,6R,8R,9S,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one Chemical compound NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(S)(=O)O[C@@H]4[C@@H](COP(S)(=O)O[C@@H]2[C@@H]3F)O[C@H]([C@H]4F)N2C=NC3=C2N=CN=C3N)C(=O)N1 YSUIQYOGTINQIN-UZFYAQMZSA-N 0.000 description 2
- HNFMVVHMKGFCMB-UHFFFAOYSA-N 3-[3-[4-(1-aminocyclobutyl)phenyl]-5-phenylimidazo[4,5-b]pyridin-2-yl]pyridin-2-amine Chemical compound NC1=NC=CC=C1C1=NC2=CC=C(C=3C=CC=CC=3)N=C2N1C1=CC=C(C2(N)CCC2)C=C1 HNFMVVHMKGFCMB-UHFFFAOYSA-N 0.000 description 2
- HCLQARMRCPEALF-DNQXCXABSA-N 3-[[(2r)-2-[(1r)-2-[[1-(1-benzothiophen-2-yl)-2-methylpropan-2-yl]amino]-1-hydroxyethyl]pyrrolidin-1-yl]methyl]benzonitrile Chemical compound C([C@@H]1[C@H](O)CNC(C)(CC=2SC3=CC=CC=C3C=2)C)CCN1CC1=CC=CC(C#N)=C1 HCLQARMRCPEALF-DNQXCXABSA-N 0.000 description 2
- MITGKKFYIJJQGL-UHFFFAOYSA-N 9-(4-chlorobenzoyl)-6-methylsulfonyl-2,3-dihydro-1H-carbazol-4-one Chemical compound ClC1=CC=C(C(=O)N2C3=CC=C(C=C3C=3C(CCCC2=3)=O)S(=O)(=O)C)C=C1 MITGKKFYIJJQGL-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229940127007 Compound 39 Drugs 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 101100024019 Mus musculus Mosmo gene Proteins 0.000 description 2
- OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 description 2
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- SMNRFWMNPDABKZ-WVALLCKVSA-N [[(2R,3S,4R,5S)-5-(2,6-dioxo-3H-pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [[[(2R,3S,4S,5R,6R)-4-fluoro-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)C2C=CC(=O)NC2=O)[C@H](O)[C@@H](F)[C@@H]1O SMNRFWMNPDABKZ-WVALLCKVSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000002168 alkylating agent Substances 0.000 description 2
- 229940100198 alkylating agent Drugs 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- IKWQWOFXRCUIFT-UHFFFAOYSA-N benzene-1,2-dicarbohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C(=O)NN IKWQWOFXRCUIFT-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 2
- 150000001805 chlorine compounds Chemical class 0.000 description 2
- 229940125758 compound 15 Drugs 0.000 description 2
- 229940126142 compound 16 Drugs 0.000 description 2
- 229940125810 compound 20 Drugs 0.000 description 2
- 229940126086 compound 21 Drugs 0.000 description 2
- 229940127573 compound 38 Drugs 0.000 description 2
- 229940125936 compound 42 Drugs 0.000 description 2
- 229940125844 compound 46 Drugs 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- JAXFJECJQZDFJS-XHEPKHHKSA-N gtpl8555 Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](B1O[C@@]2(C)[C@H]3C[C@H](C3(C)C)C[C@H]2O1)CCC1=CC=C(F)C=C1 JAXFJECJQZDFJS-XHEPKHHKSA-N 0.000 description 2
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine hydrate Chemical compound O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 229940032007 methylethyl ketone Drugs 0.000 description 2
- 229940105631 nembutal Drugs 0.000 description 2
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 2
- PIDFDZJZLOTZTM-KHVQSSSXSA-N ombitasvir Chemical compound COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC1=CC=C([C@H]2N([C@@H](CC2)C=2C=CC(NC(=O)[C@H]3N(CCC3)C(=O)[C@@H](NC(=O)OC)C(C)C)=CC=2)C=2C=CC(=CC=2)C(C)(C)C)C=C1 PIDFDZJZLOTZTM-KHVQSSSXSA-N 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 239000012264 purified product Substances 0.000 description 2
- 238000002601 radiography Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- VDZOOKBUILJEDG-UHFFFAOYSA-M tetrabutylammonium hydroxide Chemical compound [OH-].CCCC[N+](CCCC)(CCCC)CCCC VDZOOKBUILJEDG-UHFFFAOYSA-M 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 description 1
- IUSARDYWEPUTPN-OZBXUNDUSA-N (2r)-n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-[3-(1,3-thiazol-2-yl)phenyl]butan-2-yl]-2-methoxypropanamide Chemical compound C([C@H](NC(=O)[C@@H](C)OC)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2OC2(CCC2)C1)C(C=1)=CC=CC=1C1=NC=CS1 IUSARDYWEPUTPN-OZBXUNDUSA-N 0.000 description 1
- YJLIKUSWRSEPSM-WGQQHEPDSA-N (2r,3r,4s,5r)-2-[6-amino-8-[(4-phenylphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1CNC1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O YJLIKUSWRSEPSM-WGQQHEPDSA-N 0.000 description 1
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
- FMCAFXHLMUOIGG-JTJHWIPRSA-N (2s)-2-[[(2r)-2-[[(2s)-2-[[(2r)-2-formamido-3-sulfanylpropanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxy-2,5-dimethylphenyl)propanoyl]amino]-4-methylsulfanylbutanoic acid Chemical compound O=CN[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(=O)N[C@@H](CCSC)C(O)=O)CC1=CC(C)=C(O)C=C1C FMCAFXHLMUOIGG-JTJHWIPRSA-N 0.000 description 1
- FMCAFXHLMUOIGG-IWFBPKFRSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2r)-2-formamido-3-sulfanylpropanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxy-2,5-dimethylphenyl)propanoyl]amino]-4-methylsulfanylbutanoic acid Chemical compound O=CN[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(O)=O)CC1=CC(C)=C(O)C=C1C FMCAFXHLMUOIGG-IWFBPKFRSA-N 0.000 description 1
- WWTBZEKOSBFBEM-SPWPXUSOSA-N (2s)-2-[[2-benzyl-3-[hydroxy-[(1r)-2-phenyl-1-(phenylmethoxycarbonylamino)ethyl]phosphoryl]propanoyl]amino]-3-(1h-indol-3-yl)propanoic acid Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)O)C(=O)C(CP(O)(=O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1C=CC=CC=1)CC1=CC=CC=C1 WWTBZEKOSBFBEM-SPWPXUSOSA-N 0.000 description 1
- STBLNCCBQMHSRC-BATDWUPUSA-N (2s)-n-[(3s,4s)-5-acetyl-7-cyano-4-methyl-1-[(2-methylnaphthalen-1-yl)methyl]-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide Chemical compound O=C1[C@@H](NC(=O)[C@H](C)NC)[C@H](C)N(C(C)=O)C2=CC(C#N)=CC=C2N1CC1=C(C)C=CC2=CC=CC=C12 STBLNCCBQMHSRC-BATDWUPUSA-N 0.000 description 1
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 1
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 1
- HUWSZNZAROKDRZ-RRLWZMAJSA-N (3r,4r)-3-azaniumyl-5-[[(2s,3r)-1-[(2s)-2,3-dicarboxypyrrolidin-1-yl]-3-methyl-1-oxopentan-2-yl]amino]-5-oxo-4-sulfanylpentane-1-sulfonate Chemical compound OS(=O)(=O)CC[C@@H](N)[C@@H](S)C(=O)N[C@@H]([C@H](C)CC)C(=O)N1CCC(C(O)=O)[C@H]1C(O)=O HUWSZNZAROKDRZ-RRLWZMAJSA-N 0.000 description 1
- WZZBNLYBHUDSHF-DHLKQENFSA-N 1-[(3s,4s)-4-[8-(2-chloro-4-pyrimidin-2-yloxyphenyl)-7-fluoro-2-methylimidazo[4,5-c]quinolin-1-yl]-3-fluoropiperidin-1-yl]-2-hydroxyethanone Chemical compound CC1=NC2=CN=C3C=C(F)C(C=4C(=CC(OC=5N=CC=CN=5)=CC=4)Cl)=CC3=C2N1[C@H]1CCN(C(=O)CO)C[C@@H]1F WZZBNLYBHUDSHF-DHLKQENFSA-N 0.000 description 1
- TVTJUIAKQFIXCE-HUKYDQBMSA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynyl-1H-purine-6,8-dione Chemical compound NC=1NC(C=2N(C(N(C=2N=1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C)=O TVTJUIAKQFIXCE-HUKYDQBMSA-N 0.000 description 1
- ZEQHPUCQCWTFRP-UHFFFAOYSA-N 3-(1,3-dioxoisoindol-2-yl)propanoyl chloride Chemical compound C1=CC=C2C(=O)N(CCC(=O)Cl)C(=O)C2=C1 ZEQHPUCQCWTFRP-UHFFFAOYSA-N 0.000 description 1
- QBWKPGNFQQJGFY-QLFBSQMISA-N 3-[(1r)-1-[(2r,6s)-2,6-dimethylmorpholin-4-yl]ethyl]-n-[6-methyl-3-(1h-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine Chemical compound N1([C@H](C)C2=NSC(NC=3C4=NC=C(N4C=C(C)N=3)C3=CNN=C3)=C2)C[C@H](C)O[C@H](C)C1 QBWKPGNFQQJGFY-QLFBSQMISA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- FCSKOFQQCWLGMV-UHFFFAOYSA-N 5-{5-[2-chloro-4-(4,5-dihydro-1,3-oxazol-2-yl)phenoxy]pentyl}-3-methylisoxazole Chemical compound O1N=C(C)C=C1CCCCCOC1=CC=C(C=2OCCN=2)C=C1Cl FCSKOFQQCWLGMV-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229940126657 Compound 17 Drugs 0.000 description 1
- 102100036883 Cyclin-H Human genes 0.000 description 1
- 101000713120 Homo sapiens Cyclin-H Proteins 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 230000006181 N-acylation Effects 0.000 description 1
- 238000007126 N-alkylation reaction Methods 0.000 description 1
- MHABMANUFPZXEB-UHFFFAOYSA-N O-demethyl-aloesaponarin I Natural products O=C1C2=CC=CC(O)=C2C(=O)C2=C1C=C(O)C(C(O)=O)=C2C MHABMANUFPZXEB-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241001474728 Satyrodes eurydice Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- LJOOWESTVASNOG-UFJKPHDISA-N [(1s,3r,4ar,7s,8s,8as)-3-hydroxy-8-[2-[(4r)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl] (2s)-2-methylbutanoate Chemical compound C([C@H]1[C@@H](C)C=C[C@H]2C[C@@H](O)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)CC1C[C@@H](O)CC(=O)O1 LJOOWESTVASNOG-UFJKPHDISA-N 0.000 description 1
- SPXSEZMVRJLHQG-XMMPIXPASA-N [(2R)-1-[[4-[(3-phenylmethoxyphenoxy)methyl]phenyl]methyl]pyrrolidin-2-yl]methanol Chemical compound C(C1=CC=CC=C1)OC=1C=C(OCC2=CC=C(CN3[C@H](CCC3)CO)C=C2)C=CC=1 SPXSEZMVRJLHQG-XMMPIXPASA-N 0.000 description 1
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 description 1
- PSLUFJFHTBIXMW-WYEYVKMPSA-N [(3r,4ar,5s,6s,6as,10s,10ar,10bs)-3-ethenyl-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-6-(2-pyridin-2-ylethylcarbamoyloxy)-5,6,6a,8,9,10-hexahydro-2h-benzo[f]chromen-5-yl] acetate Chemical compound O([C@@H]1[C@@H]([C@]2(O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@@H]21)C=C)C)OC(=O)C)C(=O)NCCC1=CC=CC=N1 PSLUFJFHTBIXMW-WYEYVKMPSA-N 0.000 description 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 230000000397 acetylating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 150000001260 acyclic compounds Chemical class 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- FFINMCNLQNTKLU-UHFFFAOYSA-N adipiodone Chemical compound OC(=O)C1=C(I)C=C(I)C(NC(=O)CCCCC(=O)NC=2C(=C(C(O)=O)C(I)=CC=2I)I)=C1I FFINMCNLQNTKLU-UHFFFAOYSA-N 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 238000002583 angiography Methods 0.000 description 1
- 238000009341 apiculture Methods 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- XRWSZZJLZRKHHD-WVWIJVSJSA-N asunaprevir Chemical compound O=C([C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)OC1=NC=C(C2=CC=C(Cl)C=C21)OC)N[C@]1(C(=O)NS(=O)(=O)C2CC2)C[C@H]1C=C XRWSZZJLZRKHHD-WVWIJVSJSA-N 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- KGNDCEVUMONOKF-UGPLYTSKSA-N benzyl n-[(2r)-1-[(2s,4r)-2-[[(2s)-6-amino-1-(1,3-benzoxazol-2-yl)-1,1-dihydroxyhexan-2-yl]carbamoyl]-4-[(4-methylphenyl)methoxy]pyrrolidin-1-yl]-1-oxo-4-phenylbutan-2-yl]carbamate Chemical compound C1=CC(C)=CC=C1CO[C@H]1CN(C(=O)[C@@H](CCC=2C=CC=CC=2)NC(=O)OCC=2C=CC=CC=2)[C@H](C(=O)N[C@@H](CCCCN)C(O)(O)C=2OC3=CC=CC=C3N=2)C1 KGNDCEVUMONOKF-UGPLYTSKSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 210000003445 biliary tract Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 150000001717 carbocyclic compounds Chemical class 0.000 description 1
- JYYOBHFYCIDXHH-UHFFFAOYSA-N carbonic acid;hydrate Chemical compound O.OC(O)=O JYYOBHFYCIDXHH-UHFFFAOYSA-N 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- DDKMFOUTRRODRE-UHFFFAOYSA-N chloromethanone Chemical compound Cl[C]=O DDKMFOUTRRODRE-UHFFFAOYSA-N 0.000 description 1
- 238000013189 cholangiography Methods 0.000 description 1
- 229940125773 compound 10 Drugs 0.000 description 1
- 229940126208 compound 22 Drugs 0.000 description 1
- 229940125833 compound 23 Drugs 0.000 description 1
- 229940125961 compound 24 Drugs 0.000 description 1
- 229940125846 compound 25 Drugs 0.000 description 1
- 229940125851 compound 27 Drugs 0.000 description 1
- 229940127204 compound 29 Drugs 0.000 description 1
- 229940125878 compound 36 Drugs 0.000 description 1
- 229940125807 compound 37 Drugs 0.000 description 1
- 229940126540 compound 41 Drugs 0.000 description 1
- 229940127271 compound 49 Drugs 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000006196 deacetylation Effects 0.000 description 1
- 238000003381 deacetylation reaction Methods 0.000 description 1
- 230000020176 deacylation Effects 0.000 description 1
- 238000005947 deacylation reaction Methods 0.000 description 1
- 238000006389 diacetylation reaction Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- VFNGKCDDZUSWLR-UHFFFAOYSA-N disulfuric acid Chemical compound OS(=O)(=O)OS(O)(=O)=O VFNGKCDDZUSWLR-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- QFWPJPIVLCBXFJ-UHFFFAOYSA-N glymidine Chemical compound N1=CC(OCCOC)=CN=C1NS(=O)(=O)C1=CC=CC=C1 QFWPJPIVLCBXFJ-UHFFFAOYSA-N 0.000 description 1
- 101150023600 gpaA gene Proteins 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 229940029355 iodipamide Drugs 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- RENRQMCACQEWFC-UGKGYDQZSA-N lnp023 Chemical compound C1([C@H]2N(CC=3C=4C=CNC=4C(C)=CC=3OC)CC[C@@H](C2)OCC)=CC=C(C(O)=O)C=C1 RENRQMCACQEWFC-UGKGYDQZSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- AGJSNMGHAVDLRQ-IWFBPKFRSA-N methyl (2s)-2-[[(2s)-2-[[(2s)-2-[[(2r)-2-amino-3-sulfanylpropanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxy-2,3-dimethylphenyl)propanoyl]amino]-4-methylsulfanylbutanoate Chemical compound SC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)OC)CC1=CC=C(O)C(C)=C1C AGJSNMGHAVDLRQ-IWFBPKFRSA-N 0.000 description 1
- CXHHBNMLPJOKQD-UHFFFAOYSA-M methyl carbonate Chemical compound COC([O-])=O CXHHBNMLPJOKQD-UHFFFAOYSA-M 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 238000009608 myelography Methods 0.000 description 1
- LRHPLDYGYMQRHN-UHFFFAOYSA-N n-Butanol Substances CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 1
- GASFVSRUEBGMDI-UHFFFAOYSA-N n-aminohydroxylamine Chemical class NNO GASFVSRUEBGMDI-UHFFFAOYSA-N 0.000 description 1
- IOMMMLWIABWRKL-WUTDNEBXSA-N nazartinib Chemical compound C1N(C(=O)/C=C/CN(C)C)CCCC[C@H]1N1C2=C(Cl)C=CC=C2N=C1NC(=O)C1=CC=NC(C)=C1 IOMMMLWIABWRKL-WUTDNEBXSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- MBYLVOKEDDQJDY-UHFFFAOYSA-N tris(2-aminoethyl)amine Chemical compound NCCN(CCN)CCN MBYLVOKEDDQJDY-UHFFFAOYSA-N 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 238000007487 urography Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
Ovaj post.upak se odnosi na dobi jan je 2,4,6-trijodo-5- (2,4,6-tri jodo-5-amino-benzoil) amino-alkil-karbonil-amino-benzoevih kiselina formule o (1T) coouThis step relates to the age of 2,4,6-triiodo-5- (2,4,6-tri iodo-5-amino-benzoyl) amino-alkyl-carbonyl-amino-benzoic acid of formula o (1T ) coou
. j. j
C°ri>tNH-CO(CHj)n M<C ° ri> tNH-CO (CHj) n M <
YU 39658 i njihovih farmaceutski prihvatljivih soli, u kojoj radikali imaju značenja navedena u opisu, koja se koriste kao kontrastna sredstva u radiografiji, a koji je okarakterisan time što reaguje amin formule 'YU 39658 and their pharmaceutically acceptable salts, in which the radicals have the meanings indicated in the description, used as contrast agents in radiography, characterized by reacting an amine of formula '
CO'\x-XH-CO(CH) NH i u kojoj R,, R4, R2,,ni' n2' a 1 b imaju gore navedena značenja, sa hloridom kiseline formuleCO '\ x-XH-CO (CH) NH and in which R ,, R 4 , R 2 ,, n and' n 2 ' a 1 b have the meanings indicated above, with an acid chloride of the formula
r15 «16 u kojoj R2< R i R imaju navedena značenja, pri čemu se reakcija izvodi u polarnom rastvaraču, na temperaturi od 20 do 60°C i u prisustvu akceptora kiseline, i što kiselina formule II sa farmaceutski prihvatljivom bazom stvara farmaceutski prihvatljivu so. R 15 'is 16 u kojoj R 2 <R and R Eligible mentioned meanings, and the reasons why the reaction copies in polarnom solvent, at a temperature of from 20 to 60 ° C iu presence acceptor acid, and table acid of formula II with a pharmaceutically prihvatljivom bazom things pharmaceutically an acceptable are.
Oblast tehnike u koju spada pronalazak je jedinjenje formuleThe invention relates to a compound of the formula
Predmet pronalaska spada u oblast acikličnih i karbocikličnih jedinjenja, a naročito amida karbonskih kiselina u kojima su supstituenti ugljovodonične iii supstituisane ugljovodonične grupe.The subject matter of the invention is in the field of acyclic and carbocyclic compounds, in particular carboxylic acid amides in which the substituents are hydrocarbon or substituted hydrocarbon groups.
Prema Medjunarodnoj klasifikaciji patenta (MKP) predmet pronalaska je razvrstan, odnosno klasiran i označen klasifikacionim simbolom C 07C 103/76 kojim su definisani amidi karbonskih kiselina u kojima su supstituenti ugljovodonične iii supstituisane ugljovodonične grupe. Sekundarni klasifikacioni simbol predmeta pronalaska je A 61K 29/02 kojim se definišu proizvodi za radiografiju, a naročito radiološka kontrastna sredstva.According to the International Patent Classification (IPC), the subject matter of the invention is classified, respectively classified and designated by the classification symbol C 07C 103/76 defining carboxylic acid amides in which hydrocarbon substituents or substituted hydrocarbon groups are substituted. A secondary classification symbol of the subject matter of the invention is A 61K 29/02 defining products for radiography, and in particular radiological contrast agents.
Tehnički problemTechnical problem
Tehnički problem koji se rešava ovom prijavom sastoji se u sledečem: kako dobiti jedinjenja koja sadrže najmanje dva t.rijodo benzolova jezgra i samo jednu karboksilnu grupu, a koja su veoma malo toksična, imaju dobar kontrast i mogu se izraditi po postupcima u industrijskim razmerama te da su, prema torne, relativno jeftina?The technical problem to be solved by this application is the following: how to obtain compounds containing at least two ions of benzene kernels and only one carboxyl group, which are very little toxic, have good contrast and can be prepared by industrial processes and that according to tornadoes, are they relatively cheap?
Stanje tehnikeThe state of the art
U američkom patentnom spisu US 2 708 678 opisanoU.S. Patent No. 2,708,678 describes
COOHCOOH
UH - NH2 . J . .UH - NH 2 . J. .
koja sadrži dva trijodo benzolova jezgra i jednu karboksilnu grupu. Medjutim, svi pokušaji da se ovo jedinjenje dobije prema postupku opisanom u pomenutom patentnom spisu bili su bezuspešni bez obzira na uslove pod kojima je radjeno. Takodje i jedinjenja dobljena po postupcima opisanim u američkom panteritnom spisu US 7 145 197 (jotalamična kiselina), francuskom patentnom spisu F 6 777 (joksitalamična kiselina) i američkira patetnim spisima US 3 290 366 (jokarmična kiselina, US 1 076 024 {diatrizoična kiselina) i US 2 776 241 (jodipamid) nisu dala zadovoljavajuče rezultate i prednosti.containing two triiodic benzene nuclei and one carboxyl group. However, all attempts to obtain this compound according to the process described in said patent have been unsuccessful regardless of the conditions under which it was operated. Takodje and compounds obtained by postupcima described in američkom panteritnom U.S. Pat 7,145,197 (jotalamična acid) francuskom Patent file F 6777 (joksitalamična acid) and američkira patetnim specification US 3,290,366 (jokarmična acid, US 1,076,024 {diatrizoična acid) and US 2 776 241 (iodipamide) did not provide satisfactory results and benefits.
Opis reženja tehničkog problemaDescription of technical problem management
Zadatak pronalaska je da ostvari postupak za dobijanje 2,4,6-trijodo-5-(2,4,6-trijodo-5-amino-benzoil)amino-alkil-karbonil-amino-benzoevih kiselina formuleThe object of the invention is to provide a process for the preparation of 2,4,6-triiodo-5- (2,4,6-triiodo-5-amino-benzoyl) amino-alkyl-carbonyl-amino-benzoic acid of the formula
COOH '(C«2^-CC(CH2) w·COOH '(C «2 ^ - C C (CH 2 ) w ·
COF-S NH-Co(CH,) Nfl ‘ 2*τνJ (II) hCOF-S NH-Co (CH,) Nfl '2 * τνJ (II) h
N u kojoj R1 predstavlja atom vodonika, radikal formule -CD-NH-R^ gde je vodonik, metil iiiN in which R 1 represents a hydrogen atom, a radical of the formula -CD-NH-R 2 where hydrogen, methyl iii
- C2 hidroksialkil grupa, iii radikal formule / R7- a C 2 hydroxyalkyl group, or a radical of formula / R 7
N, gde su R_> i Rg nezavisno, vodonik, acetR8 iii metil grupa, R^ predstavlja vodonik, raikal formule -CO-NH-Rg gde je Rg vodonik, metil li -CH2CH2OCOCH.j grupa, iii radikal formule 'Rll gde je R vodonik iii acetil grupa, aN, where R 1 and R g are independently hydrogen, acet R 8 or methyl, R 1 represents hydrogen, a radical of the formula -CO-NH-R g where R g is hydrogen, methyl or -CH 2 CH 2 OCOCH.j a group, iii a radical of the formula ' R 11 where R is hydrogen or an acetyl group, a
Rq 2 je vodonik iii metil grupa, R je radikal formule -CONHR^ u kojoj je R * metil grupa iii x Ri i radikal formule -N gde io r , acetil, R ’ x j ii ' 12 Ri?R q 2 is hydrogen or a methyl group, R is a radical of formula -CONHR ^ in which R * is a methyl group iii x R ii is a radical of formula -N where io r, acetyl, R 'xj ii' 12 R i?
metil grupa, R je vo*aonik iii metil grupa, R je vodonik iii acetil grupa, R je atom vodonika, metil iii acetil grupa, a je 0 iii 1, n je ceo broj od 1 do 5, n2 je 0 iii 1, b je 0 iii 1, i njihovih soli sa farmaceutski prihvatljivim bazama, okarakterisan time što amin formule \X'1[ —v H .·! >methyl group, R is hydrogen * or methyl group, R is hydrogen or acetyl group, R is hydrogen atom, methyl or acetyl group, and is 0 or 1, n is an integer from 1 to 5, n 2 is 0 or 1 , b is 0 or 1, and salts thereof with pharmaceutically acceptable bases, characterized in that the amine of formula \ X'1 [—v H. >
C0-ti.C0th.
, ..., ...
>·,> Jf 1> ·,> Jf 1
-^'aii-coCcK..) i Zn..- ^ 'aii-coCcK ..) and Zn ...
u kojoj R1, r R4' ni ' n2' a I b imaju prethodno navedena značer.ja, reaguje sa hloridom kiseline formule kondenzacije čija je formulawherein R 1 , r R 4 ' n and' n 2 ' a and b have the foregoing meanings, reacts with an acid chloride of the condensation formula of which the formula
Cl-COA (Va) Rl·Cl-COA (Va) R l ·
COOHCOOH
II
- (CH^ BH-CO(CH2)n jf =ΊοΊ (Vin)- (CH ^ BH-CO (CH 2 ) n jf = ΊοΊ (Vin)
J.J.
«26 u kojoj , R i Ri 6 imaIu Prethodno navedena značenja, pri čemu se reakcija izvodi u polarnom rastvaraču, na temperaturi od 20 do 60 C i u prisustvu akceptora kiseline, i što kiselina formule II sa farmaceutski prihvatljivom bazom stvara farmaceutski prihvatljivu so.Wherein R, R and R and 6 have the meanings given in P and R in which the reaction is carried out in polar solvent at a temperature of from 20 to 60 C and in the presence of an acid acceptor, and which produces an acid of formula II with a pharmaceutically acceptable base a pharmaceutically acceptable salt.
Kod soli kiselina formule II naročito se mogu navesti soli alkalnih metala kao što su natrijum i kalijum, soli amonijuma, zemnoalkalnih metala kao sto je kalcijum i soli organskih baza kao što su etanolamin iii metilglukamin.For the salts of acids of formula II, particular reference may be made to alkali metal salts such as sodium and potassium, ammonium salts, alkaline earth metals such as calcium, and organic base salts such as ethanolamine or methylglucamine.
Prema pronalasku, jedinjenja formule II dobijaju se reakcijcm amina formule IVa u ko jo j R1 , R^, n , n ib imaju prethodno navena značenja sa hloriocm kiseline formule Va u kojoj R.>, R1 i R imaju prethodno navedena značenja.According to the invention, the compounds of formula II are prepared by the reaction of an amine of formula IVa in which R 1 , R 1 , n, n and b have the meanings indicated previously with an acid chlorine of formula Va in which R 1 , R 1 and R have the meanings given above.
G V a reakcija može, eventualno, biti pračena reakcijom N-alkilovanja, N-hidroksialkilovanja, N-acilovanja iii N-polihidroksiacilovanja, dezacetilovanja kao i reakcijama esterifikacije iii prevodjenja u seli prema konvencionalnim postupcima.The G V a reaction may optionally be followed by the reaction of N-alkylation, N-hydroxyalkylation, N-acylation or N-polyhydroxyacylation, deacetylation as well as esterification or village reactions according to conventional methods.
u kojoj a i n imaju gore navedena značenja, a R1 ' ima isto značenje kao R^, iii, u slučaju kada R^ nosi jednu hidroksi grupu, R1' predstavlja njegov proizvod acilovanja sa hloridom kiseline formule VII.in which ain has the above meanings, and R 1 'has the same meaning as R ^, iii, in the case where R ^ carries one hydroxy group, R 1 ' represents its acylation product with an acid chloride of formula VII.
Kondenzacija amina formule iv sa hloridom kiseline formule VII izvodi se, prvenstveno, u takvom polarnom rastvaraču kao što je dimetilacetamid iii dimetilformamid, na temperaturi od 20°C od 100 C, pri čemu se hlorid kiseline upotrebljava u višku. Trajanje reakcije može varirati od 2 časa do 4 dana.The condensation of an amine of formula iv with an acid chloride of formula VII is carried out, preferably, in such a polar solvent as dimethylacetamide or dimethylformamide, at a temperature of 20 ° C of 100 C, wherein the acid chloride is used in excess. The duration of the reaction can vary from 2 hours to 4 days.
Hidrazinoliza proizvoda formule VIII izvodi se na uobičejene načine, dejstvom hidrazina u vodenoj sredini (vidi Journal of American Chemical Society, 71 1856 (1949); H.R. Ing i R.F. Manske Journal of Chemical Society, 2348 (1926);Hydrazinolysis of the products of formula VIII is carried out in the usual manner, by the action of hydrazine in an aqueous medium (see Journal of the American Chemical Society, 71 1856 (1949); H.R. Ing and R.F. Manske Journal of the Chemical Society, 2348 (1926);
Chemische Berichte, 83 244 (1950). Veliki višak hidrazina se pogodno upotrebljava (4 do 8 molova po molu proizvoda formule VIII).Chemische Berichte, 83 244 (1950). A large excess of hydrazine is conveniently used (4 to 8 moles per mole of the product of formula VIII).
Amini formule IV kod kojih je N = 1, a=0, aR je niži alkil radikal mogu se takodje dobiti reagovanjem jedinjenja formuleAmines of formula IV wherein N = 1, a = 0 and aR is a lower alkyl radical can also be prepared by reacting a compound of formula
Amini formuleAmines of the formula
COOHCOOH
J JJ J
To iTo and
1^-^( CH2) a-H-C0 (CH2 ) -SH2 1 ^ - ^ (CH 2 ) a -H-C0 (CH 2 ) -SH 2
J 'J r //^Ahh-co CH2 Cl (n) (IV) sa sredstvom za alkilovanje jedinjenje formule pri čemu se dobija u ko j ima je A = O, n = 1, R^ = H, a R] = H, -CONHCHq i -NHCOCHq opisani su u američkom patentnom spisu US ’ 210 4)2.J 'J r // ^ Ahh-co CH 2 Cl (n) (IV) with an alkylating agent of the compound of the formula to obtain when j has A = O, n = 1, R ^ = H, and R ] = H, -CONHCH q, and -NHCOCH q are described in U.S. Patent No. '210 4) 2.
Amini formule IV u kojoj je R^ vodonik, mogu se dobiti kondenzacijom amina formuleThe amines of formula IV in which R1 is hydrogen can be obtained by condensation of an amine of formula
COOHCOOH
sa hloridom kiseline formulewith the acid chloride of the formula
ClCO<CH2)nl<^o^C?) (yll) pri čemu R1, a i n imaju gore navedena značenja, a zatim hidr -zir.clizom dobijen.cg proizvodaClCO <CH 2 ) n l <^ o ^ C?) (Yll) wherein R 1 , ain have the meanings given above and then hydro-zir.clizom obtained.cg of the product
u kojoj je R4 niži alkil radikal, posle čega se na tako dobijeno jedinjenje deluje sa amonijakom.in which R 4 is a lower alkyl radical, after which the compound thus obtained is treated with ammonia.
Kondenzacija jedinjenja IVa i Va izvedi se u takvom polarnom rastvaraču kao što je dimetilacetamid iii dimetilsulfoksid, na temperaturi od 20°C do 60°C i u prisustvu viška akceptora kiseline, kao što je trietilamin iii natrijum-karbonat. Trajanje reakcija može varirati od 2 časa do približno 4 dana.The condensation of compounds IVa and Va is carried out in such a polar solvent as dimethylacetamide or dimethyl sulfoxide at a temperature of 20 ° C to 60 ° C and in the presence of excess acid acceptors such as triethylamine or sodium carbonate. The duration of the reactions may vary from 2 hours to approximately 4 days.
Da bi se dobilo jedinjenje formule II u kojoj je R^ alkil iii hidroksialkil radikal, jedinjenje formule II u kojoj je R^ vodonik na klasičan način reaguje sa sredstvom za alkilovanje iii hidroksialkilovanje.In order to obtain a compound of formula II wherein R1 is alkyl or hydroxyalkyl, a compound of formula II wherein R4 is hydrogen is reacted in a conventional manner with an alkylating agent or hydroxyalkyl.
Da bi se dobilo jedinjenje formule II u kojoj jeIn order to obtain the compound of formula II in which
R niži alkanoil radikal iii polihidroksi niži alkanoil radikal, jedinjenje formule II, u kojoj su c i R-) c atomi vodonika. reaquje sa sredstvom ža aciloVanje iii polihidroksiacilovanje. Obrnuto, jedinjenja formule II u kojima su R., $ i R atomi vodonika mogu se doBiti saponifikacijom, odnosno dezacilovanjem jedinjenja formule II čiji je azot acilovan. Jedinjenje formule II u kojima je b = 2 mogu se dobiti kada se kao amin formule VI upotrebljava jedinjenje formule II u kome su R1 i R^ atomi vodonika.R is a lower alkanoyl radical or a polyhydroxy lower alkanoyl radical, a compound of formula II, in which c1- R1c are hydrogen atoms. reacts with acylating agent or polyhydroxyacylation. Conversely, compounds of formula II in which R1, R8, and R are hydrogen atoms can be obtained by saponification, or deacylation of compounds of formula II whose nitrogen is acylated. A compound of formula II in which b = 2 can be obtained when a compound of formula II is used as the amine of formula VI wherein R 1 and R 4 are hydrogen atoms.
Sledeči primeri ilustruju načine izvodjenj a pronalaska.The following examples illustrate methods of carrying out the invention.
U odeljcima A, B i C prikazani su odgovarajuči preparati amina formule IV, derivati formule V i jedinjenja formule II.Sections A, B and C show the corresponding amine preparations of formula IV, derivatives of formula V and compounds of formula II.
U ovim primerima kontrole čistoče su vršene na sledeči način:In these examples, purity controls were performed as follows:
1. Hromatografijorn na tankom sloju (HTS), na pločicama fluorescentnog silikagela (kvalitet Merk F 254) u elementima:1. Thin layer chromatography (HTS), on fluorescent silica gel plates (Merk F 254 quality) in the following elements:
- benzol/metil-etil-keton/mravlja kiselina (60:25:20) eluent 1,- benzene / methyl-ethyl-ketone / formic acid (60:25:20) eluent 1,
- etilacetat/izopropanol/amonijak (55:35:40) eluent 2,- ethyl acetate / isopropanol / ammonia (55:35:40) eluent 2,
- etilacetat/izopropanol/amonijak (35:35:40) eluent 3,- ethyl acetate / isopropanol / ammonia (35:35:40) eluent 3,
- n-butanol/sirčetna kiselina/voda (50:11:25) eluent 4.- n-butanol / acetic acid / water (50:11:25) eluent 4.
Primedba: Neki eluenti za HTS, naročito eluent 4, omogučavaju zapažanje različitih izomera kiselina koji sadrže N-metil-N-acil-amino benzoevu kiselinsku funkciju.Note: Some HTS eluents, in particular eluent 4, allow the observation of various acid isomers containing N-methyl-N-acyl-amino benzoic acid function.
Tako čisto jedinjenje formule II koje je mono N-metilovano može dati 2 mrlje (slabo razdvojene, ali istovremeno se dobro razlikuju i u količinama koje su različite zavisno od kiseline), dok di-N-metilovano jedinjenje daje 3 mrlje.Such a pure compound of formula II which is mono-N-methylated can give 2 spots (poorly separated, but at the same time differ well in amounts that are different depending on acid), while di-N-methylated compound gives 3 spots.
2. Odredjivanje čistoče posle:2. Determining the purity of the business:
- dodavanja halogena,- addition of halogens,
- dodavanja karboksilne kiseline pomoču natri jum-hidroksida, recirkulacijom,- the addition of carboxylic acid to the aid of sodium hydroxide by recirculation,
- dodavanje pokretljivog vodonika i karboksilne kiseline, pomoču natrijum-metilata, u navedenoj sredini i u prisustvu azoljubičaste boje,- the addition of mobile hydrogen and carboxylic acid, with the aid of sodium methylate, in the said environment and in the presence of an azole color,
- dodavanja rastvora karboksilne kiseline u dimetilformamidu, tetrabutilamonijum hidroksida rastvorenog u izopropanolu,- adding a solution of carboxylic acid in dimethylformamide, tetrabutylammonium hydroxide dissolved in isopropanol,
- dodavanja alifatičnih amina pomoču perhlorne kiseline u sirčetnoj kiselini.- the addition of aliphatic amines to the aid of perchloric acid in acetic acid.
A. Dobijanje amina formule XVA. Preparation of an Amine of Formula XV
Primer IExample I
Dobijanje trijodo-2,4,6-N-hidroksietil-karbamoil-3-aminoacetil-amino-5-benzoeve kiseline (jedinjenje I)Preparation of triiodo-2,4,6-N-hydroxyethyl-carbamoyl-3-aminoacetyl-amino-5-benzoic acid (Compound I)
a) Dobijanje trijodo-2,4,6-N-ftalimido-acetoksietil-karbamoil-3-ftalimidoacetilamino-5-benzoeve kiselinea) Preparation of triiodo-2,4,6-N-phthalimido-acetoxyethyl-carbamoyl-3-phthalimidoacetylamino-5-benzoic acid
COOECOOE
/.+0 J To></ | t' i «CH-COOCH.CHjiraCO /KHCOCHjS Q/.+ 0 J To></ | t 'i «CH-COOCH.CHjiraCO / KHCOCHjS Q
Rastvori se 180 g (0,3 mola) trijodo-2,4,6-N-hidroksietil-karbamoil-3-amino-5-benzoeve kiseline u 300 ml dimetilacetamida. U porcijama se doda, uz hladjenje u ledenom kupatilu, 170 g (Ο,Ι’β mola) ftaliglicin hlorida. Posle mešanja na sobnoj temperaturi preko noči, razredi se sa 1000 ml vode i stvori talog. Posle cedjenja, ispiranja vodom, cedjenja i sušenja u peči, dobija se 275 g belog proizvoda, što čini prinos od 95%.Dissolve 180 g (0.3 mol) of triiodo-2,4,6-N-hydroxyethyl-carbamoyl-3-amino-5-benzoic acid in 300 ml of dimethylacetamide. 170 g (Ο, Ι′β mole) of phthaliglycine chloride were added in portions with cooling in an ice bath. After stirring at room temperature overnight, dilute with 1000 ml of water and create a precipitate. After straining, washing with water, straining and drying in a furnace, 275 g of white product are obtained, which gives a 95% yield.
Kontrola čistoče:Cleanliness control:
Rf polazne trijodo kiseline 0,4Rf of starting acid triad 0.4
Rf polaznog ftalilglicina 0,77Rf of starting phthalylglycine 0.77
Rf proizvoda kondenzacije 0,68Rf of the condensation product 0.68
b) Dobijanje trijodo-2,4,6-N-hidroksietil-karbamoii-3-amino-acetamino-5-benzoeve kiselineb) Preparation of triiodo-2,4,6-N-hydroxyethyl-carbamoyl-3-amino-acetamino-5-benzoic acid
JJ
HOCH2CH2NhCOHOCH 2 CH 2 NhCO
COOH <J (COCHgC^COOH <J (COCHgC ^
JJ
Susoenduje se 19^ g (0,20 mola) prethodnog proizvoda u 600 mi vode i 60 g hidrazinhidrata (1,20 mla) i zagreva na 80 C uz mešanje tokom 2 časa, pri čemu dolazi do rastvaranja. Tokom reakcije dolazi do kristalizacije. Posle hladjenja, cedjenja, ispiranja i sušenja u sušnici izoluje se 125 g proizvoda, što čini prinos od 95%.It condenses 19 ^ g (0.20 mol) of the previous product in 600 m of water and 60 g of hydrazinhydrate (1.20 m) and is heated to 80 C with stirring for 2 hours, dissolving. Crystallization occurs during the reaction. After cooling, straining, rinsing and drying in the oven, 125 g of product is isolated, yielding a 95% yield.
Kontrola čistoče:Cleanliness control:
1. HTS eluent 11. HTS eluent 1
Rf polaznog proizvoda 0,68 Rf dobijenog proizvoda 0,05Starting Product Rf 0.68 Product Starting Rf 0.05
Izazivanjem sa ninhidrinom pojavljuje se žuto-narandžasta mrlja.When challenged with ninhydrin, a yellow-orange stain appears.
2. Čistoča proizvoda posle dodavanja joda: 97,7% Čistoča proizvoda posle dodavanja natrijum-hidroksida: 100%2. Product purity after iodine addition: 97,7% Product purity after sodium hydroxide addition: 100%
Primer IIExample II
Dobijanje trijodo-2,4,6-N-metilkarbamoil-3-gama-amino-butiril-amino-5-benzoeve kiseline (jedinjenje II)Preparation of triiodo-2,4,6-N-methylcarbamoyl-3-gamma-amino-butyryl-amino-5-benzoic acid (compound II)
Postupak je isti kao za jedinjenje I, samo što se kao polazni proizvod koji sadrži jod upotrebljava trijodo-2,4,6-N-metil-karbaraoil-3-amino-5-benzoeva kiselina, a kao hlorid kiseline - hlorid-gama-ftalimidc-buterne kiseline.The procedure is the same as for Compound I, except that triodo-2,4,6-N-methyl-carbaraoyl-3-amino-5-benzoic acid is used as the starting product containing iodine and acid chloride-gamma- phthalimid-butyric acids.
Primer IIIExample III
Dobijanje trijodo-2,4,6-N-metil-karbamoil-3-amino-acetilamino-5-benzoeve kiseline (jedinjenje III)Preparation of triiodo-2,4,6-N-methyl-carbamoyl-3-amino-acetylamino-5-benzoic acid (compound III)
Postupak je isti kao za jedinjenje I, samo što je kao polazni proizvod upotrebljen trijodo-2,4,6-N-metil-karbamcil-0-amino-5-benzoeva kiselina .The procedure is the same as for compound I, except that triodo-2,4,6-N-methyl-carbamyl- O- amino-5-benzoic acid was used as the starting product.
Osim toga, izvodi se još jedno prečiščevanje sircvog proizvoda. Regeneriše se pomoču etanola na 95 C (oko 3000 g/5 litara) . Posle refluksovanja se filtrira na toplo. Ukupan prinos od kondenzacij0 i prečiščavanja je 62,5%.In addition, another purification of the raw product is performed. It is regenerated using ethanol at 95 C (about 3000 g / 5 liters). After refluxing, it is filtered warm. The total yield from condensation 0 and purification is 62.5%.
Primer IVExample IV
Dobijanje trijodo-2,4,6-acetamido-3-amino-acetamido-metil-5-benzoeve kiselinePreparation of triiodo-2,4,6-acetamido-3-amino-acetamido-methyl-5-benzoic acid
Postupak je isti kao za jedinjenje I, samo što je polazni proizvod trijodo-2,4,6-acetamido-q-aminometil-5-benzoeva kiselina koja se dobija pod sledečim uslovima:The procedure is the same as for Compound I, except that the starting material is triiodo-2,4,6-acetamido- q -aminomethyl-5-benzoic acid, which is obtained under the following conditions:
rastvori se 111 g (0,177 mola) trijodo-2,4,6—acetamido— 3—acetamidometi1—5—benzoeve kiseline (prema švajcarskom patentnom spisu CH 1+.788/62) u 220 ml ION natrijum-hidroksida i drži 2 časa na 70°C. Posle hladjenja na 0 C podesi se na pH 7 pomoču koncentrovane hlorovodonične kiseline. Ostavi se da kristališe preko noči u hladnjaku. Posle cedjenja, ispiranja sa vodom, cedjenja i sušenja u sušnici, dobija se 100 g proizvoda, što čini prinos 96%.dissolve 111 g (0.177 mol) of triiodo-2,4,6-acetamido-3-acetamidomethyl 1-5-benzoic acid (according to Swiss Patent File CH 1 + .788 / 62) in 220 ml of ION sodium hydroxide and hold for 2 hours at 70 ° C. After cooling to 0 C, adjust to pH 7 with concentrated hydrochloric acid. Allow to crystallize overnight in the refrigerator. After straining, rinsing with water, straining and drying in the oven, 100 g of product are obtained, yielding 96%.
Kontrola čistoče:Cleanliness control:
1. HTS eluent 21. HTS eluent 2
Rf polaznog proizvoda 0,30 Rf dobijenog proizvoda 0,25Rf of starting product 0,30 Rf of starting product 0,25
2. Čistoča proizvoda posle dodavanja joda 99,5% Kondenzacija 2,4,6-trijodo-acetamido-3-aminometil-5-benzoeve kiseline i hlorida ftalilglicina. Rastvori se 100 g (0,17 mola) trijodo kiseline u 200 ml dimetilacetamida i doda 55 g hlorida ftalilglicina (0,25 mola). Rastvor se ostavi da preko noči reaguje na sobnoj temperaturi. Posle 24 časa se doda još 20 g hlorida ftalilglicina, a posle 24 časa i treči put dodaje se hlorid ftalilglicina u količini od 45 g.2. Purity of product after iodine addition 99.5% Condensation of 2,4,6-triiodo-acetamido-3-aminomethyl-5-benzoic acid and phthalylglycine chloride. Dissolve 100 g (0.17 mol) of triiodic acid in 200 ml of dimethylacetamide and add 55 g of phthalylglycine chloride (0.25 mol). The solution was allowed to react at room temperature overnight. After 24 hours, another 20 g of phthalylglycine chloride was added, and after 24 hours a third time, 45 g of phthalylglycine chloride was added.
proizvod se taloži, ispira, cedi, suši, a zatim hidrazinolizuje kao kod jedinjenja I.the product is precipitated, washed, strained, dried, and then hydrazinolized as in compound I.
Primer VExample V
Dobijanje trijodo-2,4,6-eta-arainokaproilamino-3-benzoeve kiseline (jedinjenje V)Preparation of triiodo-2,4,6-eta-arainocapylamino-3-benzoic acid (compound V)
Postupak je isti kao za jedinjenje 1, samo što se kao polazni proizvodi upotrebljavaju trijodo-2,4,6-amino-l’-benzoeva kiselina i hlorid-eta-ftalilidokapronske kiseline.The procedure is the same as for compound 1 except that triodo-2,4,6-amino-l'-benzoic acid and chloride-eta-phthalylidocaproic acid are used as starting products.
Primer VIExample VI
Dobijanje trijodo-2,4,6-amino-acetamido-3-benzoeve kiseline (jedinjenje VI)Preparation of triiodo-2,4,6-amino-acetamido-3-benzoic acid (compound VI)
Postupak je isti kao za jedinjenje I, samo što se kao polazni proizvod, koji sadrži jod, upotrebljava trijodo-2,4,6-amino-3-benzoeva kiselina.The procedure is the same as for Compound I, except that triodo-2,4,6-amino-3-benzoic acid is used as the starting product containing iodine.
Primer VIIExample VII
Dobijanje trijodo-2,4,6-acetamido-3-aminoacetamido-5-benzoeve kiseline (jedinjenje VII)Preparation of triiodo-2,4,6-acetamido-3-aminoacetamido-5-benzoic acid (compound VII)
Postupak je isti kao za jedinjenje I, samo sto se kao polazni proizvod, koji sadrži jod, upot.rebljava trijodo-2,4,6-acetamido-3-amino-5-benzoeva kiselinaThe procedure is the same as for Compound I, except that triodo-2,4,6-acetamido-3-amino-5-benzoic acid is used as the starting product containing iodine
Primer VIIIExample VIII
Dobijanje trijodo-2,4,6-N-metil-karbamiol-3-N-metil-N-aminoacetilamino-5-benzoeve kiseline (jedinjenje VIII)Preparation of triiodo-2,4,6-N-methyl-carbamiol-3-N-methyl-N-aminoacetylamino-5-benzoic acid (Compound VIII)
a) Trijodo-2,4je-N-metil-karbamoil-^-N-metil-hloracetamido-5-benzoeva kiselina:a) Triiodo-2,4 is-N-methyl-carbamoyl - N - N-methyl-chloroacetamido-5-benzoic acid:
.380 ml dimetilsulfata dodaje se, kap po kap, na temperaturi izmedju 5 C i 10 C, rastvoru od 1300 g (2 mola) trijodo-2,4,6-N-metil-karbamil-3-hloracetamido-5-benzoeve kiseline (prema američkom patentnora spisu US 3 210 412) u rastvoru 2N natrijum-karbonata (3 litra). Kada se dodavanje završi, ostavi se da se ohladi na sobnoj temperaturi i nastavi sa mešanjem 20 časova. Filtrira se za uklanjanje nerastvorivih materija, a zatim se zakiseli do pH 1 sa koncentrovanom hlorovodoničnom kiselinom. Talog se cedi, ispira nekoliko puta sa vodom i osuši na 60 C. Prečiščavanje se izvodi rastvaranjem proizvoda u 900 ml 2N natrijum-karbonata i ekstrakcijom pomoču 1000 g natri jum-hlorida. Posle mešanja od 24 časa na sobnoj temperaturi, talog se cedi, a zatim ponovo rastvara u 2500 ml vode. Filtrira se, zatim se zakiseli do pH 1 pomoču koncentrovane hlorovodonične kiseline. Posle ispiranja sa vodom, cedjenja, sušenja na 60 C dobija se 672 g (prinos 51%) proizvoda..380 ml of dimethylsulfate is added dropwise at a temperature of between 5 C and 10 C to a solution of 1300 g (2 mol) of triiodo-2,4,6-N-methyl-carbamyl-3-chloroacetamido-5-benzoic acid. (according to U.S. Patent No. 3,210,412) in a solution of 2N sodium carbonate (3 liters). When the addition is complete, allow to cool to room temperature and continue stirring for 20 hours. It is filtered to remove insoluble matter and then acidified to pH 1 with concentrated hydrochloric acid. The precipitate was filtered, washed several times with water and dried at 60 C. Purification was performed by dissolving the product in 900 ml of 2N sodium carbonate and extracting with the aid of 1000 g of sodium sulfate. After stirring for 24 hours at room temperature, the precipitate was filtered off and then redissolved in 2500 ml of water. It is filtered, then acidified to pH 1 with concentrated hydrochloric acid. After washing with water, straining, drying at 60 C, 672 g (51% yield) of the product is obtained.
Kontrola čistoče:Cleanliness control:
1. HTS eluent 21. HTS eluent 2
Rf polaznog proizvoda 0,1Starting Product Rf 0.1
Rf metilovanog proizvoda 0,2 i 0,25 (2 izomera)Rf of methylated product 0.2 and 0.25 (2 isomers)
2. Čistoča: dodavanje joda 97%2. Purity: 97% addition of iodine
Čistoča: dodavanje hlora 104%Purity: addition of chlorine 104%
b) Trijodo-2,4,6-N-metil-karbamoil-3-N-metil-N-aminoacetilamino-5-benzoeva kiselina:b) Triiodo-2,4,6-N-methyl-carbamoyl-3-N-methyl-N-aminoacetylamino-5-benzoic acid:
314 g (0,49 mola) prethodno dobijene kiseline rastvori se u 3500 ml koncentrovanog amonijaka i zagreva tokom 20 časova na 60 C. Posle uparavanja do suva u vakuumu, doda se 300 ml vode izakiseli sa anhidridom sumporaste kiseline. Ostavi se 48 časova u hladnjaku radi kristaliranja, a zatira očedi, ispira više puta sa vodom i suši u sušnici na 80 C. Pri tom se dobija 160 g (prinos 51%) proizvoda.314 g (0.49 mol) of the acid obtained previously was dissolved in 3500 ml of concentrated ammonia and heated for 20 hours at 60 C. After evaporation to dryness in vacuo, 300 ml of water was acidified with sulfuric acid anhydride. It is left in the refrigerator for 48 hours to crystallize and then it is quenched, washed repeatedly with water and dried in an oven at 80 C. This gives 160 g (51% yield) of the product.
Kontrola čistoče:Cleanliness control:
1. HTS eluent 31. HTS eluent 3
Rf dobijenog proizvoda 0,75Rf of the obtained product 0.75
2. Čistoča: dodavanje u natrijum-karbonat 102% Čistoča: dodavanje u natrijum-metilat 98%2. Purity: Addition to Sodium Carbonate 102% Purity: Addition to Sodium Methylate 98%
Primer IXExample IX
Dobijanje trijodo-2,4,6-N-metilkarbamoil-3-(trijodo-2,4,6-N-metil-N-acetilamino-3-amino-acetilamino-5-benzoil)-glicilamino-5-benzoeve kiseline (jedinjenje IX)Preparation of Triodo-2,4,6-N-Methylcarbamoyl-3- (triiodo-2,4,6-N-methyl-N-acetylamino-3-amino-acetylamino-5-benzoyl) -glycylamino-5-benzoic acid ( compound IX)
Postupak je isti kao za jedinjenje I, samo što se kao polazni proizvod, koji sadrži jod, upotrebljava trijodo-2,4,6-N-metil-karbamoil-3-(trijodo-2,4,6-N-metil-N-acetilamino-3-amino-5-benzoil)glicilamino-5-benzoeva kiselina (jedinjenje 15 koje je kasnije opisano), pri čemu je dužina reakcije veča (4 dana na sobnoj temperaturi).The procedure is the same as for Compound I, except that triiodo-2,4,6-N-methyl-carbamoyl-3- (triiodo-2,4,6-N-methyl-N is used as the starting product containing iodine -acetylamino-3-amino-5-benzoyl) glycylamino-5-benzoic acid (compound 15 described later), the reaction being longer (4 days at room temperature).
Primer XExample X
Dobijanje trijodo-2,4,6-N-metil-N-amino-acetilamino-3-benzoeve kiseline (jedinjenje X)Preparation of triiodo-2,4,6-N-methyl-N-amino-acetylamino-3-benzoic acid (compound X)
a) Dobijanje trijodo-2,4,6-hloroacetamido-3-benzoeve kiseline. Izvodi se prema američkom patentnom spisu US 3 210 412.a) Preparation of triiodo-2,4,6-chloroacetamido-3-benzoic acid. It is performed according to U.S. Patent No. 3 210 412.
Kontrola čistoče:Cleanliness control:
1. HTS eluent 21. HTS eluent 2
Rf proizvoda od koga se polazi 0,3 Rf dobijenog proizvoda 0,25The product's Rf starting from 0.3 Rf of the resulting product is 0.25
2. Čistoča posle dodavanja u natrijum-karbonat 99,8%2. Purity after addition to sodium carbonate 99,8%
b) Trijodo-2, 4, 6-N-metil-N-hloroacetilamino-3-benzoeva kiselina:b) Triiodo-2, 4, 6-N-methyl-N-chloroacetylamino-3-benzoic acid:
Rastvori se 591,5 g (1 mol) prethodno dobijenog proizvoda u 2,3 mola 5N natrijum-karbonata i 100 ml acetona.Dissolve 591.5 g (1 mol) of the previously obtained product in 2.3 moles of 5N sodium carbonate and 100 ml of acetone.
Dodaje se, kap po kap, 1,3 mola metiljodida uz održavanje temperature na 10 C pomoču vodenog kupatila. Posle mešanja tokom 16 časova na sobnoj temperaturi, reakciona smeša se izlije u 2 litra razredjene hlorovodonične kiseline od 1/10, uz hladjenje u ledenom kupatilu. Istaloženi proizvod se cedi i ispira vodom više puta. Posle sušenja u sušnici na 50°C dobija se 591 g, što čini prinos od 85%.1.3 moles of methyl iodide were added dropwise while maintaining the temperature at 10 ° C using a water bath. After stirring for 16 hours at room temperature, the reaction mixture was poured into 2 liters of 1/10 diluted hydrochloric acid, cooled in an ice bath. The precipitated product is drained and washed with water several times. After drying in an oven at 50 ° C, 591 g is obtained, which yields an 85% yield.
Kontrola čistoče:Cleanliness control:
1. HTS eluent 21. HTS eluent 2
Rf polaznog proizvoda 0,25Starting product Rf 0.25
Rf metilovanog proizvoda (razdvajanje 2 izomera) 0,35 i 0,45Rf of methylated product (separation of 2 isomers) 0.35 and 0.45
2. Čistoča posle dodavanja hlora 92%2. Purity after chlorine addition 92%
Čistoča posle dodavanja joda 100%Purity after adding iodine 100%
Čistoča posle dodavanja natrijum-metilata 92%Purity after addition of sodium methylate 92%
c) Trijodo-2, 4, 6-N-metil-N-aminoacetilamir.o-i-benzoeva kiselina:c) Triiodo-2, 4, 6-N-methyl-N-aminoacetylamyr.-1-benzoic acid:
Rastvori se 590 g (0,90 mola) prethodr.c dobljene kiseline u 9 litara koncentrovar.og amonijaka. Rastvaranje je skcro potpuno, samo se filtriranjem ukloni 3 g nerastvorive materije koju čini metil-estar polazne kiseline.Dissolve 590 g (0.90 mol) of precursor acid obtained in 9 liters of concentrated ammonia. The dissolution is complete, with only filtration to remove 3 g of the insoluble matter formed by the starting acid methyl ester.
Dobijeni rastvor (svetložute boje) se zagreva 20 časova na 60 C, a zatim se koncentruje na 2 litra u vakuumu, pri čemu dolazi do kristalisanja amonijumove soli. Zatim se cedi, pcnovo rastvara u 500 ml vode i minimalnoj zapremini natrijum-karbonata, i ponovo taloži sa sirčetnom kiselinom pri pH 4. Posle cedjenja, ispiranja sa vodom, cedjenja i sušenja, dobija se Ί6 g belog proizvoda, što čini prinos od 52%.The resulting solution (light yellow color) was heated at 60 C for 20 hours and then concentrated to 2 liters in vacuo to give ammonium salt crystallization. It is then filtered, dissolved in 500 ml of water and a minimum volume of sodium carbonate, and re-precipitated with acetic acid at pH 4. After straining, washing with water, straining and drying, g6 g of white product is obtained, yielding 52 %.
Kontrola čistoče:Cleanliness control:
1. HTS eluent 11. HTS eluent 1
Rf polaznog proizvoda 0,9Starting Product Rf 0.9
Rf dobijenog proizvoda 0,25, sa ninhidrinom se dobija žuta mrljaRf of the obtained product 0.25, with ninhydrin a yellow stain is obtained
2. Čistoča posle dodavanja u natrijum - karbonat2. Purity after addition to sodium carbonate
98,5%98.5%
Čistoča posle dodavanja u natrijum - metilatPurity after addition to sodium methylate
100%100%
Primer XXExample XX
Dobijanje trijcdo-2,4,6-N-gama-aminobutiril-amir.o-3-benzoeve kiseline (jedinjenje XI)Preparation of trido-2,4,6-N-gamma-aminobutyryl-amino-3-benzoic acid (compound XI)
Primenjuje se isti postupak kao za jedinjenje II, samo što se kao polazni proizvod, koji sadrži jod, upotrebljava trijodo-2,4,6-amino-3-benzoeva kiselinaThe same procedure as for Compound II applies, except that triodo-2,4,6-amino-3-benzoic acid is used as the starting product containing iodine
U ovom slučaju je potrebno da se sirovi dobijeni proizvod prečisti rastvaranjem ’50 g u 4 litra vede i 280 ml koncentrovane sumporne kiseline. Nerastvorene nečistoče se filtriraju, a rastvor neutrališe. Zatim se amin ponovo istaložava sa sirčetnom kiselinom pri pH 4. Pri torne se dobija 309 g prečiščenog proizvoda.In this case, it is necessary to purify the crude product obtained by dissolving '50 g in 4 liters of satin and 280 ml of concentrated sulfuric acid. The undissolved impurities are filtered and the solution neutralized. The amine is then re-precipitated with acetic acid at pH 4. 309 g of the purified product are obtained.
Primer XIIExample XII
Dobijanje trijodo-2,4,6-beta-amino-propionil-amino-3-benzoeve kiseline (jedinjenje XII)Preparation of triiodo-2,4,6-beta-amino-propionyl-amino-3-benzoic acid (compound XII)
Postupak je isti kao za jedinjenje I, samo što se kao polazni proizvod, koji sadrži jod, upotrebljava trijodc-2,4,6-amino-3-benzoeva kiselina i hlorid beta-ftalimidopropionske kiseline.The procedure is the same as for Compound I, except that triodec-2,4,6-amino-3-benzoic acid and beta-phthalimidopropionic acid chloride are used as the starting product containing iodine.
Primer XIIIExample XIII
Dobijanje trijodo-2,4,6-N-metil-N-acetilamino-3-aminc-acetamido-5-benzoeve kiseline (jedinjenje XIII)Preparation of triiodo-2,4,6-N-methyl-N-acetylamino-3-aminecacetamido-5-benzoic acid (compound XIII)
Postupak je isti kao za jedinjenje I, samo što se kao polazni proizvod, koji sadrži jod, upotrebljava trijodo-2,4-6-N-metil-N-acetil-amino-3-amino-5-benzoeva kiselina (prema američkom patentnom spisu US 3 178 4-1) sa sledečim odlikama:The procedure is the same as for compound I, except that triodo-2,4-6-N-methyl-N-acetyl-amino-3-amino-5-benzoic acid (according to U.S. Pat. US 3 178 4- 1 ) with the following characteristics:
1. Proizvod kondenzacije sa ftalilglicinom ispira se (ispira se 1554 g u 2 litra etilalkchola na 95°C! i izoluje se 1200 g prečiščenog proizvoda.1. The condensation product with phthalylglycine is washed off (washing 1554 g in 2 liters of ethyl alkaline at 95 ° C) and isolating 1200 g of the purified product.
2. Sirovi proizvod dobijen hidrazinciizom se prečiščava rastvaranjem 26-1 g u 550 ml razredjene sumporne kiseline od 1/10 na 80°C.2. The resultant crude product was purified by dissolving hidrazinciizom 26 -1 gu 550 ml razredjene sulfuric acid of 1/10 at 80 ° C.
g ftalilhidrazida formuleg of phthalylhydrazide of formula
filtrira se na toplo i uklanja.it is filtered warm and removed.
Sumporni filtrat se obradjuje filtriranjem preko drvenog uglja i neutrališe se sa amonijakom do pH 4 do 5. Posle kristalizacije, ispiranja sa vodom, cedjenja i sušenja u sušnici na 70 C, a zatim na 105 C, dobija se 211 g belog proizvoda.The sulfur filtrate is filtered through charcoal filtration and neutralized with ammonia to pH 4 to 5. After crystallization, washing with water, straining and drying at 70 C and then at 105 C, 211 g of white product are obtained.
3. Obradom tečnosti od hidrazinolize sa sumporneni kiselinom, na toplo, izoluje se 390 g belog proizvoda istog kvaliteta kao i prethodno debijenih 211 g.3. By treating the hydrazinolysis fluid with sulfuric acid, 390 g of a white product of the same quality as 211 g previously deboned are isolated in warm.
Primer xivExample xiv
Dcbijanje trijodo-2,4,6-N-hidroksietil-karbamoil-3-aminobutiril-amino-5-benzoeve kiseline (jedinjenje XIV)Combination of tridio-2,4,6-N-hydroxyethyl-carbamoyl-3-aminobutyryl-amino-5-benzoic acid (compound XIV)
Postupak je isti kao za jedinjenje II, samo što se kao polazni proizvod upotrebljava trijodo-2,4,6-K-hidroksietil-karbamil-3-amino-5-benzoeva kiselina.The procedure is the same as for compound II, except that triodo-2,4,6-K-hydroxyethyl-carbamyl-3-amino-5-benzoic acid is used as the starting product.
Primer XVExample XV
Dobijanje trijodo-2,4,6-N-metil-karbamoil-3(trijodo-2,4,6-N-metil-karbamoil-3-aminoacetamido-5-benzoil)glicil-N-metilamino-5-benzoeve kiseline Postupak je isti kao za jedinjenje I, samo što se kao polazni proizvod upotrebljava jedinjenje 14a koje če biti kasnije opisano.Preparation of triiodo-2,4,6-N-methyl-carbamoyl-3 (triiodo-2,4,6-N-methyl-carbamoyl-3-aminoacetamido-5-benzoyl) glycyl-N-methylamino-5-benzoic acid Procedure is the same as for Compound I, except Compound 14a is used as starting material, which will be described later.
Primer XVIExample XVI
Dobijanje trijodo-2,4,6-(trijodo-2,4,6-N-metil-karbamoil-3-aminoacetamido-5-benzoil)glicilamino-5-benzoeve kiseline (jedinjenje XVI)Preparation of triiodo-2,4,6- (triiodo-2,4,6-N-methyl-carbamoyl-3-aminoacetamido-5-benzoyl) glycylamino-5-benzoic acid (compound XVI)
Postupak je isti kao za jedinjenje I, samo što s e kao polazni proizvod, koji sadrži jod, upot.rebljava jedinjenje 34 koje če kasnije biti opisano.The procedure is the same as for Compound I, except that as the starting material containing iodine, it uses Compound 34, which will be described later.
Primer XVIIExample XVII
Dobijanje trijoda-2,4,6-N-hidroksietil-karbamoil-?- (trijodo-2,4,6-N-metil-karbamoil-3-aminoacetamido-5-benzoil)glicil-amino-5-benzoeve kiseline (jedinjenje XVII)Preparation of triiod-2,4,6-N-hydroxyethyl-carbamoyl -? - (triiodo-2,4,6-N-methyl-carbamoyl-3-aminoacetamido-5-benzoyl) glycyl-amino-5-benzoic acid (compound XVII)
Postupak je isti kao za jedinjenje I, samo što se kac polazni proizvod upotrebljava jedinjenje ?a koje če biti opisano kasnije.The procedure is the same as for compound I, except that the starting material is the compound used, which will be described later.
Primer XVIIIExample XVIII
Dobijanje trijodo-2,4,6-N-metil-karbamoil-3-amino-propionil-amino-5-benzoeve kiseline (jedinjenje XVIII)Preparation of triiodo-2,4,6-N-methyl-carbamoyl-3-amino-propionyl-amino-5-benzoic acid (compound XVIII)
Postupak j<= isti kac za jedinjenje I, samo što se kao polazni proizvod upotrebljava trijodo-2,4,G-N-metilkarbamoil-^-amino-S-benzoeva kiselina.Process j <= same kac for compound I, except that triodo-2,4, N-methylcarbamoyl-N-amino-S-benzoic acid is used as the starting product.
Primer XXVIIIExample XXVIII
Deti janje trijodc-2,4,6-karbamoil-3-amino-acetamido-5-benzoeve kiseline (jedinjenje XXVIII) Postupak je isti kao kod jedinjenje I, samo što se za kondenzaciiu sa ftalil-alicinhloridom kao polazni proizvod upotrebljava trijodo-2,4,6-karbamoil-?-amino-5-benzoeva kiselina.Treatment of triiodic-2,4,6-carbamoyl-3-amino-acetamido-5-benzoic acid (compound XXVIII) The procedure is the same as for compound I except that triodo-2 is used as a starting material for condensation with phthalyl-allin chloride , 4,6-Carbamoyl -? - amino-5-benzoic acid.
Hidrazinoliza se izvodi na sledeči način:Hydrazinolysis is performed as follows:
4,85 mola prethodno dobijenog proizvoda se rastvara u 4,850 1 vode i 940 ml hidrazin-hidrata. Posle mešanja tokom 24 časa na sebnoj temperaturi, dobljeni talog se cedi i osuši. Dobija se 2,1 kg suveg proizvoda koji sadrži ftalilhidrazid. 1,88 kg oveg proizvoda se ispira 2 puta pod refluksom u 3,8 litra etanola, cedi se na toplo4.85 moles of the previously obtained product were dissolved in 4,850 l of water and 940 ml of hydrazine hydrate. After stirring for 24 hours at ambient temperature, the resulting precipitate was filtered off and dried. 2. 1 kg of dry product containing phthalylhydrazide is obtained. 1.88 kg of this product is washed twice under reflux in 3.8 liters of ethanol, sizzling warm
TABLICA i bistri sa toplim etanolom. Posle sušenja se dobija 1,566 kg suvog proizvoda što čini ukupan prinos od 52%.TABLE and clear with warm ethanol. After drying, 1.566 kg of dry product is obtained which makes a total yield of 52%.
Kontrola čistoče:Cleanliness control:
1. HTS eluent 11. HTS eluent 1
Rf polaznog proizvoda 0,65 Rf dobijenog proizvoda 0,00Rf of starting product 0.65 Rf of starting product 0.00
2. Čistoča proizvoda posle dodavanja joda 91,5%. U Tablici I prikazani su podaci koji se odnose na dobijanje amina formule IV kondenzacijom i hidrazinolizom, kao i podaci za tako dobijene amine; dok su u Tablici II prikazani podaci koji se odnose na dobijanje amina formule iv polazeči od hloriranih derivata formule IX, kao i podaci za tako dobljene amine.2. Product purity after iodine addition 91.5%. Table I shows the data relating to the preparation of amines of formula IV by condensation and hydrazinolysis, as well as data for the amines thus obtained; while Table II shows the data related to the preparation of amines of formula iv starting from chlorinated derivatives of formula IX, as well as data for the amines thus obtained.
II
ukupantotal
1) Pgsle iapiranja na toplo u dimetilf oimamidu.1) Pgsle iaping warm in dimethyl oimamide.
2) 0 eluentu benzol/metil-etil-keton/raravlja kiselina (8o/20/l0)2) 0 eluent benzene / methyl-ethyl-ketone / carboxylic acid (8o / 20 / l0)
TABLICA IITABLE II
Polazni tri- Hlorovani kondenzacionl Amin , ,_i jodo proizvod _ proizvod_ _Starting Tri- Chlorinated Condensing Amine,, _and Iodo Product _ Product_ _
Rf u eluentu Rf a elu-Rf u elu- Prinos Rf u elu- kf u p , entu 2 entu 1 entu 1 eluen- 373:1110 tu 2Rf in eluent Rf a elu-Rf in elu- Yield Rf in elu- kf in p , entu 2 entu 1 entu 1 eluen- 373: 1110 tu 2
Tablici III prikazani su podaci o dobljenim aminima opšte formule IV.Table III shows the information of the amines of general formula IV obtained.
TABLICA IIITABLE III
COOHCOOH
J / J ’ O !J / J 'O!
H OC H2 CH2NHC(>-\^ATiH C OC H2 NH2 JH OC H 2 CH 2 NHC (> - \ ^ A TiH C OC H 2 NH 2 J
IIII
COOHCOOH
101.1 0 1.
CHjiraco _/ahhco(ch2)3nh2 CHjiraco _ / a hhco (ch 2 ) 3 nh 2
IIIIII
jj
NHC0CH2NH2 NHC0CH 2 NH 2
JJ
CH2NHCOCH2NH2 CH 2 NHCOCH 2 NH 2
VIVI
VIIVII
VIIIVIII
IXIX
COOHCOOH
HC0CH2KHC0HC0CH 2 KHC0
CH5-S-COCH5 CH 5 -S-COCH 5
NHCOCHjNHjNHCOCHjNHj
XIXI
COOHCOOH
JJ
OOh
-NHCO(CH2)3NH2 -NHCO (CH 2 ) 3 NH 2
XIIXII
COOHCOOH
J 'K' JJ 'K' J
NHCO(CH2)2NH2 NHCO (CH 2 ) 2 NH 2
COOH CONHCHjCOOH CONHCHj
J J jONHCHJ J jONHCH
COOH mi J ΥθΥCOOH mi J ΥθΥ
HOCE2CB2NHCO'J-\./''- nhcoch2hhcHOCE 2 CB 2 NHCO ' J - \ ./''- nhcoch 2 hhc
J J J J
COOHCOOH
XVIII jH^HCOXVIII jH ^ HCO
JJ
NHCO(CH2)2ira2 NHCO (CH 2 ) 2 ira 2
COOH JYvJ COOH J Yv J
XXVIII C hh2co aAnhcoch2nh2 XXVIII C hh 2 co aAnhcoch 2 nh 2
S. Dobijanje derivata formule VS. Preparation of Derivatives of Formula V
Primer XIXExample XIX
Dobijanje hlorida trijodo-2,4,6-N-metil-krabamoil->-N-acetil-N-metil-amino-5-benzoeve kiseline (jedinjenje XIX)Preparation of triiodo-2,4,6-N-methyl-crabamoyl -> - N-acetyl-N-methyl-amino-5-benzoic acid chloride (compound XIX)
Suspenduje se 50 g trijodo-2,4,6-metilkarbamoil-3-N-acetil-N-metilamino-5-benzceve kiseline (opisane u francuskom patentnom spisu F 2 085 6?6) u 90 ml tionilhlcrida i zagreva se uz mešanje na 65 C tokom 5 časova. Dobijeni rastvor se ostavi da se hladi. Posle cedjenja i ispiranja hlorida kiseline sa diizopropiletrom. Proizvod se osuši u vakuumu.Suspend 50 g of triiodo-2,4,6-methylcarbamoyl-3-N-acetyl-N-methylamino-5-benzoic acid (described in French patent F 2 085 6? 6) in 90 ml of thionyl chloride and stir with stirring at 65 C for 5 hours. The resulting solution was allowed to cool. After straining and washing the acid chloride with diisopropylether. The product is dried in vacuo.
□obija se 37 g proizvoda, što cini prinos od 73%.37 37 g of product is boiled, which gives a yield of 73%.
Kontrola čistoče-.Cleanliness control-.
HTS posle reakcije sa propilaminom, u višku dimetilacetamida: eluent 1 Rf polaznog proizvoda 0,5HTS after reaction with propylamine, in excess dimethylacetamide: eluent 1 Rf starting product 0.5
Rf proizvoda kondenzacije sa propilaminom 0,85Condensation product rf with propylamine 0.85
Primer XX □obijanje trijodo-2,4,6-met.ilkarbamoil-3-amino-5-benzo«ve kiseline (jedinjenje XX)Example XX □ Trihydro-2,4,6-methylcarbamoyl-3-amino-5-benzoic acid (Compound XX)
Postupak je isti kao za jedinjenje XIX, samo što se kao polazni proizvod upotrebljava tri jodo-2,4,6-N-metilkarbamoil-3-amino-5-benzoeva kiselina. Prinos je 85%.The procedure is the same as for compound XIX except that three iodo-2,4,6-N-methylcarbamoyl-3-amino-5-benzoic acid is used as the starting product. The yield is 85%.
Kontrola čistoče:Cleanliness control:
1. HTS: isti postupak kao za prethodni proizvod, ali posle kondenzacije sa etanolaminom Rf polazne kiseline 0,81. HTS: same procedure as for the previous product but after condensation with ethanolamine Rf starting acid 0.8
Rf proizvoda kondenzacije 0,4Condensation product Rf 0.4
2. HTS u eluentu aceton/hloroform/sirčetna kiselina (50:40:10)2. HTS in eluent acetone / chloroform / acetic acid (50:40:10)
Rf kiseline 0,55 Rf hlorida kiseline 0,95Acid Rf 0.55 Rf Acid Chloride 0.95
Primer XXIExample XXI
Dobijanje hlorida trijodo-2,4,6-N-metil-N-acetil-amino-5-benzoeve kiseline (jedinjenje. XXI) Postupak je ist.i kao za jedinjenje XIX, samo što se kao polazni proizvod upotrebljava trijodo-2,4,-6-N-metil-N-acetilamino-3-benzoeva kiselina. Prinos je 85%.Preparation of triiodo-2,4,6-N-methyl-N-acetyl-amino-5-benzoic acid chloride (Compound XXI) The procedure is the same as for Compound XIX, except that triodo-2 is used as the starting product. 4,6-N-Methyl-N-acetylamino-3-benzoic acid. The yield is 85%.
Primer XXIIExample XXII
Dobijanje hlorida trijodo-2,4,6-N-metil-karbamoil-.?-N-diacetil-amino-5-benzoeve kiseline (jedinjenje XXII)Preparation of triiodo-2,4,6-N-methyl-carbamoyl-N- diacetyl-amino-5-benzoic acid chloride (compound XXII)
a) Diacetilovanje trijodo-2,4,6-N-metilkarbamoil-.3-amino-5-benzoeve kiseline (opisano u američkom patentnom spisu US 3 145 197)a) Diacetylation of triiodo-2,4,6-N-methylcarbamoyl-3-amino-5-benzoic acid (described in U.S. Patent No. 3,145,197)
800 g tri jodo kiseline (1,4 mola) u 1,6 litra anhidrida sirčetne kiseline zagreva se na 120 C preko noči. Posle hladjenja se nerastvoreni deo od 123 g, što predstavlja polazni proizvod, filtrira. Reakciona tečnost se lagano izlije preko 3 litra vode sa 1 kg leda. Tom prilikom dobijaju se dve faze koje se dekantiraju. Donja faza se regeneriše sa 2,4 litra vode, pri čemu se dobija smola koja se ponovo rastvara u 800 ml sircetne kiseline. Ovaj razstvor se istaložava dodavanjem 5,4 litra vode sa 1 kg leda. Posle cedjenja i ispiranja sa vodom dobija se 500 g vlažnog proizvoda koji se kao takav upotrebljava.800 g of three iodic acid (1.4 mol) in 1.6 liters of acetic anhydride are heated to 120 C overnight. After cooling, the undissolved portion of 123 g, which is the starting product, is filtered. The reaction liquid is gently poured over 3 liters of water with 1 kg of ice. On this occasion two phases are decanted. The lower phase is regenerated with 2.4 liters of water to give a resin which is redissolved in 800 ml of acetic acid. This solution precipitates by adding 5.4 liters of water with 1 kg of ice. After straining and rinsing with water, 500 g of a wet product is obtained which is used as such.
b) Dobijanje hlorida kiseline.b) Preparation of acid chloride.
500 g sirovog proizvoda se postepeno dodaje. u 830 ml tionilhlorida, pri čemu dolazi do sniženja temperature. Posle 30 minuta dodaje se još 300 ml tionilhlorida, a posle daljih 30 minuta još 400 ml tionilhlorida. Reakcija se završava posle zagrevanja tokom 2 časa na temperaturi od 70°C. Tionilhlorid se upari u vakuumu, regeneriše u benzolu, a zatim upari u vakuumu do suva. Regeneracija sa benzolom i uparavar.je se vrše dva puta.500 g of crude product is gradually added. in 830 ml of thionyl chloride, resulting in a decrease in temperature. After 30 minutes, another 300 ml of thionyl chloride was added, followed by another 400 ml of thionyl chloride after a further 30 minutes. The reaction was terminated after heating for 2 hours at 70 ° C. The thionyl chloride is evaporated in vacuo, regenerated in benzene and then evaporated in vacuo to dryness. Regeneration with benzene and evaporation is done twice.
Na ovaj način se dobija 305 g proizvoda boje prirodne vune, što čini ukupan prinos od ,8% u odnosu na trijodo-2,4,6-N-metil-karbamoil-3-amino-5-benzoevu kiselinu od koje se pošlo.In This way to afford 305 g of product buoy Natural wool hundred ranks Total yield of 8% in relation to the triiodo-2,4,6-N-methyl-carbamoyl-3-amino-5-benzoevu kiselinu of Koje is run out Since.
Kontrola čistoče:Cleanliness control:
Postupak je isti kao za jedinjenje XIX posle kondenzacije sa propilaminom.The procedure is the same as for compound XIX after condensation with propylamine.
). HTS eluent aceton/hloroform/sirčetna kiselina (5:4:1) Rf = 0,8’). HTS eluent acetone / chloroform / acetic acid (5: 4: 1) Rf = 0,8 '
2. Čisteča posle dodavanja joda: 97%2. Purity after iodine addition: 97%
Čistoča posle dodavanja u metilatu: 101%Purity after addition in methylate: 101%
Primer XXIIIExample XXIII
Dobijanje hlorida trijodo-2,4,6-N-acetoksiet.ilkarbamoil-l-N-diacetilamino-5-benzoeve kiseline (jedinjenje XXIII)Preparation of Triiodo-2,4,6-N-Acetoxyethylcarbamoyl-1-N-diacetylamino-5-benzoic acid chloride (Compound XXIII)
a) Triacetilovanje trijodo-2,4,6-N-hidroksietil-karbamoil-3-amino-5-benzoeve kiseline.a) Triacetylation of triodo-2,4,6-N-hydroxyethyl-carbamoyl-3-amino-5-benzoic acid.
60,2 g (0,1 mola) trijodo-2,4,6-N-hidroksietil-karbamoil-l-amino-5-benzoeve kiseline rastvori se u 150 ml anhidrida sirčetne kiseline i zagreva na 160 C tokom 48 časova. Posle hladjenja, rastvor se izlije u 250 ml vode. Stvara se smola koja se regeneriše 3 puta sa po 150 ml hloroforma. Kloroform se ispere 2 puta sa po 100 ml vode, a zatim osuši preko kalcijumhlorida. Posle filtriranja, uparava se u vakuumu i dobija 60 g uljnog proizvoda sto čini prinos od 82%.60.2 g (0.1 mol) of triiodo-2,4,6-N-hydroxyethyl-carbamoyl-1-amino-5-benzoic acid were dissolved in 150 ml of acetic anhydride and heated to 160 C for 48 hours. After cooling, the solution is poured into 250 ml of water. A resin is created which is regenerated 3 times with 150 ml of chloroform each. The chloroform was washed twice with 100 ml of water each and then dried over calcium chloride. After filtration, it was evaporated in vacuo to give 60 g of an oil product, yielding an 82% yield.
Kontrola čistoče:Cleanliness control:
1. HTS eluent 11. HTS eluent 1
Rf t.riacetilovar.cg proizvoda 0,75Rf t.riacetilovar.cg product 0.75
2. Dodavanje: proizvod nije izolovan2. Addition: The product is not insulated
b) Dobijanje hlorida kiseline g (0,082 mola) trijodo-2,4,6-N-acetoksietil-karbaiuoil-?-diacetilamino-5-benzoeve kiseline se rastvori u 150 ml tionilhlorida.b) Preparation of acid chloride g (0.082 mol) of triiodo-2,4,6-N-acetoxyethyl-carboxyloyl-? - diacetylamino-5-benzoic acid was dissolved in 150 ml of thionyl chloride.
Rastvor se održava na temperaturi od 80°C tokom 4 časa. Posle uparavanja u vakuumu, ostatak se regeneriše sa 100 ml hloroforma. Nerastvorivi ostatak se uklanja, a hlorid kiseline istaložava laganim i dugotrajnim dodavanjem etiletru. Posle cedjenja i sušenja, dobija se 45 g, što čini prinos od 73% računato na triacetilovani proizvod.The solution was maintained at 80 ° C for 4 hours. After evaporation in vacuo, the residue was recovered with 100 ml of chloroform. The insoluble residue is removed and the acid chloride is precipitated by light and long-term addition to ethyl ether. After straining and drying, 45 g are obtained, which gives a yield of 73% calculated on the triacetylated product.
Kontrola čistoče:Cleanliness control:
1. HTS eluent 11. HTS eluent 1
Rf hlora kiseline 0,9Acid chlorine Rf 0.9
2. Dodavanje: proizvod nije izolovan proizvoda, što čini prinos od 6”%.2. Addition: The product is not an isolated product, which makes a yield of 6 ”%.
Kontrola čistoče:Cleanliness control:
1. HTS eluent 11. HTS eluent 1
Rf polaznog proizvoda 0,45 Rf dobijenog proizvoda 0,8Rf of starting product 0.45 Rf of starting product 0.8
2. Čistoča posle dodavanja joda: 100%2. Purity after adding iodine: 100%
Primer XXIXExample XXIX
Dobijanje hlorida trijodo-2,4,6-karbamoil-3-amino-5-benzoeve kiseline (jedinjenje XXIX)Preparation of triiodo-2,4,6-carbamoyl-3-amino-5-benzoic acid chloride (compound XXIX)
1,024 kg trijodo-2,4,6-karbamoil-3-amino-5-benzoeve kiseline se doda u 1,2 litra tionil-hlorida, a rastvor se, uz mešanje, održava na temperaturi od 80°C tokom 7 časova. Zatim se održava na sobnoj temperaturi preko noči i najzad cedi i bistri dva puta sa po 250 ml tionil-hlorida. Posle toga se ispira sa 3 litra izopropiletra i osuši na vazduhu.1,024 kg of triiodo-2,4,6-carbamoyl-3-amino-5-benzoic acid was added to 1.2 liters of thionyl chloride and the solution was stirred at 80 ° C with stirring for 7 hours. It is then maintained at room temperature overnight and finally strained and clear twice with 250 ml of thionyl chloride each. It is then washed with 3 liters of isopropyl ether and air-dried.
Dobija se 920 g proizvoda, što čini prinos od 87%.920 g of product are obtained, yielding an 87% yield.
Kontrola čistoče:Cleanliness control:
1. HTS1. HTS
Postupak je isti kao za proizvod XIX Eluent: aceton/hloroform/sirčetna kiselina (50:40)The procedure is the same as for product XIX Eluent: acetone / chloroform / acetic acid (50:40)
Rf kiseline 0,3Acid Rf 0.3
Rf proizvoda kondenzacije 0,85The condensation product Rf is 0.85
2. Čistoča posle dodavanja joda: 91%2. Purity after iodine addition: 91%
Čistoča posle dodavanja hlora: 90%Purity after chlorine addition: 90%
U Tablici IV prikazane su formule dobljenih hlorida kiselina, kao i drugih več poznatih hlorida kiselina koji se upotrebljavaju za dobijanje jedinjenja opšte formule II.Table IV shows the formulas of the acid chlorides obtained, as well as other already known acid chlorides used to prepare the compounds of general formula II.
TABLICA IVTABLE IV
Primer XXIVExample XXIV
Dobijanje hlorida trijodo-2,4,6-N-acetoksietilkarbamoil-5-N-metil-N-acetilamino-5-benzoeve kiseline (jedinjenje XXIV)Preparation of Triiodo-2,4,6-N-Acetoxyethylcarbamoyl-5-N-methyl-N-acetylamino-5-benzoic acid chloride (Compound XXIV)
a) Acetilovanje trijodo-2,4,6-N-hidroksietil-karbamoil-3-N-metil-N-acetilamino-5-benzoeve kiselinea) Acetylation of triodo-2,4,6-N-hydroxyethyl-carbamoyl-3-N-methyl-N-acetylamino-5-benzoic acid
157 g (2 mola) acetilhlorida se dodaje u suspenziju od 658 g (1 mol) trijodo-2,4,6-N-hidroksietil-karbamoil-3-N-metil-N-acetamido-5-benzoeve kiseline (opisane u francuskom patentnom spisu F 2 074 734) u 2 litra dioksana.157 g (2 mol) of acetyl chloride was added to a suspension of 658 g (1 mol) of triiodo-2,4,6-N-hydroxyethyl-carbamoyl-3-N-methyl-N-acetamido-5-benzoic acid (described in French F 2 074 734) in 2 liters of dioxane.
Suspenzija se zagreva na 80 C tokom 20 časova, pri čemu dolazi do rastvaranja. Posle uparavanja dioksana pod vakuumom, dobija se 700 g kiseline, što čini prinos od 100%.The suspension was heated to 80 C for 20 hours, dissolving. Evaporation of the dioxane under vacuum afforded 700 g of acid, yielding 100%.
Kontrola čistoče:Cleanliness control:
1. HTS eluent 11. HTS eluent 1
Rf polaznog proizvoda 0,25 Rf dobijenog proizvoda 0,45Rf of starting product 0.25 Rf of starting product 0.45
2. Čistoča posle dodavanja: proizvod nije izolovan2. Purity after addition: the product is not insulated
b) Dobijanje hlorida kiseline.b) Preparation of acid chloride.
790 g (1 mol) dobijene kiseline rastvori se u 1200 ml tionilhlorida i zagreva tokom 2 časa na 50°C.790 g (1 mol) of the resulting acid was dissolved in 1200 ml of thionyl chloride and heated for 2 hours at 50 ° C.
Tom prilikom dobija se erveni rastvor iz koga se posle 48 časova stajanja u hladnjaku izdvaja kristalan proizvod, cedjenjem. Posle ispiranja sa izopropiletrom i sušenja, dobija se 485 gOn this occasion an arsenic solution is obtained from which, after 48 hours of standing in the refrigerator, a crystalline product is separated, by straining. After washing with isopropyl ether and drying, 485 g are obtained
XIXXIX
XXXX
XXIXXI
XXIIXXII
C0C1C0C1
COC1COC1
COCHj coch3 COCHj coch 3
XXIIIXXIII
C0C1C0C1
CH5COOCH2CH2NHOO'1 CH 5 COOCH 2 CH 2 NHOO ' 1
COCH5 COCH 5
COCHjCOCHj
XXIVXXIV
COC1COC1
JJ
CH,COOCH9CH.NHCO /NC0CH, ? ί ί Ύ , 5CH, COOCH 9 CH.NHCO / NC0CH,? ί ί Ύ, 5
J CH3 J CH 3
COC1COC1
XXVXXV
NH<J \cOCH,NH <J \ cOCH,
J CH,J CH,
JJ
C. Dobijanje jedinjenje formule IIC. Preparation of Compound of Formula II
Primer 1.Example 1.
Dobijanje trijodo-2,4,6-N-hidroksietilkarbamoil-3-trijodo-2,4,6-N-metilkarbamoil-'!-N-metil- N -acetilaraino-5-benzoil-glicilamino-5-benzoeve kiseline (jedinjenje 1)Preparation of triiodo-2,4,6-N-hydroxyethylcarbamoyl-3-triido-2,4,6-N-methylcarbamoyl-1 ! -N-methyl- N -acetylaryano-5-benzoyl-glycylamino-5-benzoic acid (compound 1)
a) Kondenzacijaa) Condensation
165 g (0,25 mola) trijodo-2,4,6-N-hidroksietilkarbamoil-3-amino-acetamido-5-benzoeve kiseline (jedinjenje I) se suspenduje u smeši dimetilacetamida (250 ml) i trietilamina (58,50 g). U ovu suspenziju se doda 163 g hlorida trijodo-2,4,6-N-metil-karbamoi1-3-N-metil-N-acetilamino-5-benzoeve kiseline (jedinjenje XIX) (0,25 mola). Smeša se snažno meša na 50 C tokom 6 časova. Pomoču hromatografije na tankom sloju (HTS) dokazano je da ostaje inanje od 'ΐ polaznog proizvoda.165 g (0.25 mol) of triiodo-2,4,6-N-hydroxyethylcarbamoyl-3-amino-acetamido-5-benzoic acid (compound I) was suspended in a mixture of dimethylacetamide (250 ml) and triethylamine (58.50 g ). To this suspension was added 163 g of the triiodo-2,4,6-N-methyl-carbamoyl-3-N-methyl-N-acetylamino-5-benzoic acid chloride (compound XIX) (0.25 mol). The mixture was stirred vigorously at 50 C for 6 hours. Thin layer chromatography (HTS) has proven that it remains the '' starting material ''.
Rastvor se izlije i 1240 ml vode. stvara se neznatan talog koji se očedi. U filtrat se doda hlorovodonična kiselina do jako kiselog pH, a zatim se cedim ispira sa vodom i osuši u sušnici na 80 C. Dobija se 186 g sirovog proizvoda, što čini prinos od 61%.The solution is poured into 1240 ml of water. an insignificant precipitate is created which becomes clear. Hydrochloric acid was added to the filtrate to a very acidic pH, then the mixture was washed with water and dried in an oven at 80 C. 186 g of crude product were obtained, yielding 61%.
Kontrola čistoče:Cleanliness control:
1. HTS eluent 11. HTS eluent 1
Ri polaznog amina 0,05 Rf hlorida kiseline 0,80 Rf proizvoda kondenzacije 0,15R 1 of starting amine 0.05 Rf acid chloride 0.80 Rf condensation product 0.15
2. Čistoča proizvoda posle dodavanja natrijum - karbonata 95% čistoča proizvoda posle dodavanja metilata 98,5%2. Product purity after addition of sodium carbonate 95% purity of the product after addition of methylate 98,5%
Čistoča proizvoda posle dodavanja joda 97%Product purity after iodine addition of 97%
b) Prečiščevanjeb) Purification
Postiže se kristalizacijom na toplo u etanolu na 95 C. 186 g se suspenduje u 400 ml etanola na 95 C i drži se pod refluksom. Posle 6 časova dolazi do potpunog rastvaranja, a zatim se proizvod kristališe. Ukupno zagrevanje traje 36 časova. Zatim se ostavi da se ohladi.It is achieved by crystallization by warming in ethanol at 95 C. 186 g is suspended in 400 ml of ethanol at 95 C and kept under reflux. After 6 hours complete dissolution occurs and then the product crystallizes. Total warm-up takes 36 hours. It is then allowed to cool.
Posle cedjenja, vlažan proizvod se rastvara u 400 ml vode i natri j um-karbonata. pH se podesi na 4 - 5 pomoču sirčetne kiseline i propusti se dva puta kroz drveni ugalj. Filtrira se, a zatim zakiseli do jako kiselog pH sa koncentrovanom hlorovodoničnom kiselinom.After straining, the wet product is dissolved in 400 ml of water and sodium hydroxide. The pH was adjusted to 4 - 5 with acetic acid and passed through charcoal twice. It is filtered and then acidified to a strongly acidic pH with concentrated hydrochloric acid.
Posle filtriranja, ispiranja sa vodom, cedjenja i sušenja, dobija se 115 g čistog proizvoda, sto čini prinos od 62%.After filtration, washing with water, straining and drying, 115 g of pure product are obtained, yielding 62%.
Kontrola čistoče:Cleanliness control:
1. HTS kao kod koncentracije1. HTS as in concentration
2. Čistoča proizvoda posle dodavanja natrijum karbonata 101%2. Product purity after addition of sodium carbonate 101%
Čistoča proizvoda posle dodavanja u metilat 98,5%Product purity after addition to methylate 98,5%
Čistoča posle dodavanja joda 100,5%Purity after iodine addition 100.5%
Primer 2Example 2
Dobiianje trijodo-2,4,6-N-metilkarbamoil-3-(trijodo-2,4,6~N-metilkarbamoil-3-N-nietil-acetamido-5-benzoil)-gama-arainobutiril-amino-5-benzoeve kiseline (jedinjenje 2)Preparation of triiodo-2,4,6-N-methylcarbamoyl-3- (triiodo-2,4,6 ~ N-methylcarbamoyl-3-N-methyl-acetamido-5-benzoyl)-gamma-arainobutyryl-amino-5-benzoyl acids (compound 2)
Radi se kod jedinjenja 1 polazeči od amina II i hlorida kiseline XIX.This is for compound 1 starting from amine II and acid chloride XIX.
Primer 3.Example 3.
Dobijanje trijodo-2,4,6-N-hidroksietil-karbamoil-3-(trijodo-2,4,6-N-metil-karbamoil-3-acetamido-5-benzoil)-glicilamino-5-benzoeve kiseline (jedinjenje 3)Preparation of triodo-2,4,6-N-hydroxyethyl-carbamoyl-3- (triiodo-2,4,6-N-methyl-carbamoyl-3-acetamido-5-benzoyl) -glycylamino-5-benzoic acid (compound 3 )
Dobija se pomoču dva postupka:It is assisted by two procedures:
a) polazeči od trijodo-2,4,6-N-hidroksietil-karbamoil-3-(trijodo-2,4,6-metil-karbamoil-3-amino-5-benzoil)-glicilamino-5-benzoeve kiseline (jedinjenje '“a) . Prvo se dobija jedinjenje 3a radeči kao kod jedinjenja 1, a polazeči od amina I i hlorida kiseline XX. Jedinjenje 3 se dobija acetiiovanjem jedinjenja 3a.a) starting from triiodo-2,4,6-N-hydroxyethyl-carbamoyl-3- (triiodo-2,4,6-methyl-carbamoyl-3-amino-5-benzoyl) -glycylamino-5-benzoic acid (compound '' A). First, compound 3a was prepared as in compound 1, starting with amine I and acid chloride XX. Compound 3 is obtained by acetylation of compound 3a.
b) Polazeči od trijodo-2,4,6-N-hidroksietil-karbamoil-3-(trijodo-2,4,6-N-metilkarbamoil-3-diacetilamino-5-benzoil)-glicilamino-5-benzoeve kiseline (jedinjenje 3b). Prvo se dobija jedinjenje 3b radeči kao kod jedinjenja 1, a polazeči od amina I i hlorida kiseline XXII. Jedinjenje 3 se dobija saponifikacijom jedinjenja 3b.b) Starting from triiodo-2,4,6-N-hydroxyethyl-carbamoyl-3- (triiodo-2,4,6-N-methylcarbamoyl-3-diacetylamino-5-benzoyl) -glycylamino-5-benzoic acid (compound 3b). First, compound 3b is prepared as in compound 1, starting from amine I and acid chloride XXII. Compound 3 is obtained by saponification of compound 3b.
Primer 4Example 4
Dobijanje trijodo-2,4,6-N-metil-karbamoil-3-(trijodo-2,4,6-N-hidroksietil-karbamoil-3-N-acetilamino-5-benzoil)-gama-aminobutirilamino-5-benzoeve kiseline (jedinjenje 4)Preparation of triiodo-2,4,6-N-methyl-carbamoyl-3- (triiodo-2,4,6-N-hydroxyethyl-carbamoyl-3-N-acetylamino-5-benzoyl)-gamma-aminobutyrylamino-5-benzoyl acids (compound 4)
a) Prvo se dobija trijodo-2,4,6-N-metilkarbamoil-3-(trijodo-2,4,6-N-acetoksietilkarbamoil-3-N12a) First, triiodo-2,4,6-N-methylcarbamoyl-3- (triiodo-2,4,6-N-acetoxyethylcarbamoyl-3-N12) is obtained
-diacetilamino-5-benzoil)-gama-amino-butirilamino-5-benzoeva kiselina (jedinjenje 4a)-diacetylamino-5-benzoyl)-gamma-amino-butyrylamino-5-benzoic acid (compound 4a)
Radi se kao kod jedinjenja 1, ali polazeči od amina II i hlorida kiseline XXIII. b) Jedinjenje 4 se dobija saponifikacijom jedinjenja 4a.It works as with compound 1 but starting with amine II and acid chloride XXIII. b) Compound 4 is obtained by saponification of compound 4a.
Primer 5Example 5
Dobijanje trijodo-2,4,6-acetamido-3-(trijodo-2,Preparation of triiodo-2,4,6-acetamido-3- (triiodo-2,
4.6- N-metilkarbamoil-3-N-metilacetamido-5-benzoil)-glicilmetilamino-5-benzoeve kiseline (jedinjenje 5)4.6- N-methylcarbamoyl-3-N-methylacetamido-5-benzoyl) -glycylmethylamino-5-benzoic acid (compound 5)
Radi se kao kod jedinjenja 1, ali polazeči od amina IV i hlorida kiseline XIXIt works as with compound 1 but starting with amine IV and acid chloride XIX
Primer 6Example 6
Dobij anje trijodo-2,4,6-N-hidroksietil-karbamoi1—3 —(trijodo-2,4,6-acetamido-3-N-metil-acetamido-5-benzoil)-glicilamino-5-benzoeve kiseline (jedinjenje 6)Preparation of Triodo-2,4,6-N-Hydroxyethyl-carbamoyl-3- (triiodo-2,4,6-acetamido-3-N-methyl-acetamido-5-benzoyl) -glycylamino-5-benzoic acid (compound 6)
a) Trijodo-2,4,6-N-hidroksietil-karbamoil-3-(trijodo-2, 4, 6-amino-3-N-metil-acetamido-5-benzoil)-glicilamino-5-benzoeva kiselina (jedinjenje 6a)a) Triiodo-2,4,6-N-hydroxyethyl-carbamoyl-3- (triiodo-2,4, 6-amino-3-N-methyl-acetamido-5-benzoyl) -glycylamino-5-benzoic acid (compound 6a)
Radi se kao kod jedinjenja 1, ali polazeči od amina I i hlorida kiseline XXV.It works as with compound 1 but starting with amine I and acid chloride XXV.
b) Jedinjenje 6 se dobija acetilovanjem jedinjenja 6ab) Compound 6 is obtained by acetylation of compound 6a
Primer n Example n
Dobijanje trijodo-2,4,6-N-metil-karbamoil-3-(trijodo-2,4,6-N-hidroksietil-karbamoil-3-N-metil-acetamido-5-benzoil)-gama-amino-butirilamino-5-benzoeve kiseline (jedinjenje 7)Preparation of triiodo-2,4,6-N-methyl-carbamoyl-3- (triiodo-2,4,6-N-hydroxyethyl-carbamoyl-3-N-methyl-acetamido-5-benzoyl)-gamma-amino-butyrylamino -5-benzoic acids (compound 7)
a) Trijodo-2,4,6-N-metil-karbamoil-3-(trijodo-2,a) Triiodo-2,4,6-N-methyl-carbamoyl-3- (triiodo-2,
4.6- N-acetoksietil-karbamoil-3-N-metilacetamido-5-benzoil)-aminobutiril-amino-5-benzoeva kiselina (jedinjenje 7a)4.6- N-Acetoxyethyl-carbamoyl-3-N-methylacetamido-5-benzoyl) -aminobutyryl-amino-5-benzoic acid (compound 7a)
Radi se kao kod jedinjenja 1, ali polazeči od amina II i hlorida kiseline XXIVIt works as with compound 1 but starting from amine II and acid chloride XXIV
b) Jedinjenje 7 se dobija saponifikacijom jedinjenja 7ab) Compound 7 is obtained by saponification of compound 7a
Primer 8Example 8
Dobijanje trijodo-2,4,6-N-metilkarbamoil-3-(trijcdo-2,4,6-N-hidroksietilkarbamoil-3-N-metil-acetamido-5-benzoil)-glicilamino-5-benzoeva kiselina (jedinjenje 8)Preparation of triiodo-2,4,6-N-methylcarbamoyl-3- (tridido-2,4,6-N-hydroxyethylcarbamoyl-3-N-methyl-acetamido-5-benzoyl) -glycylamino-5-benzoic acid (compound 8 )
a) Trijodo-2,4,6-N-metil-karbamoil-3-(trijodo-2,a) Triiodo-2,4,6-N-methyl-carbamoyl-3- (triiodo-2,
4.6- N-acetoksietil-karbamoil-3-N-metil-acetamido-5-benzoil)-glicilamino-5-benzoeva kiselina (jedinjenje 8a)4.6- N-Acetoxyethyl-carbamoyl-3-N-methyl-acetamido-5-benzoyl) -glycylamino-5-benzoic acid (compound 8a)
Radi se kao kod jedinjenja 1, ali polazeči od amina III i hlorida kiseline XXIVIt works as with compound 1 but starting with amine III and acid chloride XXIV
b) Jedinjenje 8 se dobija saponifikacijom jedinjenja 8ab) Compound 8 is obtained by saponification of compound 8a
Primer 9Example 9
Dobijanje trijodo-2,4,6-N-metil-karbamoil-3-(trijodo-2,4,6-N-metil-karbamoil-3-N-metil-acetamido-5-benzoil)-glicilamino-5-benzoeve kiseline (jedinjenje 9)Preparation of triiodo-2,4,6-N-methyl-carbamoyl-3- (triiodo-2,4,6-N-methyl-carbamoyl-3-N-methyl-acetamido-5-benzoyl) -glycylamino-5-benzoyl acids (compound 9)
Radi se kao kod jedinjenja 1, ali polazeči od amina III i hlorida kiseline XIX.It works as with compound 1 but starting from amine III and acid chloride XIX.
Primer 10Example 10
Dobijanje trijodo-2,4,6,-(trijodo-2,4,6-N-metilkarbamoil- 3-N-metil-acetamido-5-benzoil) -eta-amino-kaproilamino-5-benzoeve kiseline (jedinjenje 10)Preparation of triiodo-2,4,6, - (triiodo-2,4,6-N-methylcarbamoyl-3-N-methyl-acetamido-5-benzoyl) -eta-amino-caproylamino-5-benzoic acid (compound 10)
Radi' se kao kod jedinjenja 1, ali polazeči od amina V i hlorida kiseline XIX.It works as with compound 1 but starting from amine V and acid chloride XIX.
Primer 11Example 11
Dobijanje trijodo-2,4,6-N-metil-karbamoil-3-(trijodo-2,4,6-N-metilacetamido-3-benzoil)-gama-amino-butirilamino-5-benzoeve kiseline (jedinjenje 11)Preparation of triodo-2,4,6-N-methyl-carbamoyl-3- (trido-2,4,6-N-methylacetamido-3-benzoyl)-gamma-amino-butyrylamino-5-benzoic acid (compound 11)
Radi se kao kod jedinjenja 1, ali polazeči od amina II i hlorida kiseline XXI.It works as with compound 1 but starting from amine II and acid chloride XXI.
Primer 12Example 12
Dobijanje trijodo-2,4,6-(trijodo-2,4,6-acetamido-3-benzoil)-glicilamino-3-benzoeve kiseline (jedinjenje 12)Preparation of triiodo-2,4,6- (triiodo-2,4,6-acetamido-3-benzoyl) -glycylamino-3-benzoic acid (compound 12)
a) Trijodo-2,4,6-(trijodo-2, 4, 6-amino-3-benzoil)-glicilamino-3-benzoeva kiselina (jedinjenje 12a)a) Triiodo-2,4,6- (triiodo-2,4,4,6-amino-3-benzoyl) -glycylamino-3-benzoic acid (compound 12a)
Radi se kao kod jedinjenja 1, ali polazeči od amina VI i hlorida kiseline XXVI.It works as with compound 1 but starting from amine VI and acid chloride XXVI.
b) Jedinjenje 12 se dobija acetilovanjem jedinjenja 12ab) Compound 12 is obtained by acetylation of compound 12a
Primer 13Example 13
Dobijanje trijodo-2,4-6-(trijodo-2,4,6-N-metil-acetamido-3-benzoil)-glicil-N-metilamino-3-benzoeve kiseline (jedinjenje 13)Preparation of triiodo-2,4-6- (triiodo-2,4,6-N-methyl-acetamido-3-benzoyl) -glycyl-N-methylamino-3-benzoic acid (compound 13)
Radi se kao kod jedinjenja 1, ali polazeči od amina X i hlorida kiseline XXI.It works as with compound 1 but starting from amine X and acid chloride XXI.
Primer 14Example 14
Dobijanje trijodc-2,4,6-N-metil-karbamoil-3-(trijodo-2,4,6-N-metilkarbamoil-?-acetamido-5-benzoil)-glicil-N-metilamino-5-benzoeve kiseline (jedinjenje 14)Preparation of tridoc-2,4,6-N-methyl-carbamoyl-3- (trido-2,4,6-N-methylcarbamoyl -? - acetamido-5-benzoyl) -glycyl-N-methylamino-5-benzoic acid ( compound 14)
a) Trijodo-2,4,6-N-metil-karbamoil-3-(trijodo-2,a) Triiodo-2,4,6-N-methyl-carbamoyl-3- (triiodo-2,
4.6- N-metil-karbamoil-3-amino-5-benzoil)-glicil-N-metilamino-5-benzoeva kiselina (jedinjenje 14a)4.6- N-Methyl-carbamoyl-3-amino-5-benzoyl) -glycyl-N-methylamino-5-benzoic acid (compound 14a)
Radi se kao kod jedinjenja 1, ali polazeči od amina VIII i hlorida kiseline XX.It works as with compound 1 but starting from amine VIII and acid chloride XX.
b) Jedinjenje 14 se dobija acetilovanjem jedinjenja 14ab) Compound 14 is obtained by acetylation of compound 14a
Primer 15Example 15
Dobijanje trijodo-2,4,6-N-metil-karbamoil-3-(trijodo-2, 4, 6-N-metil-acetamido-3-amino-5-benzoil)-glicilamino-5-benzoeve kiseline (jedinjenje 15)Preparation of triiodo-2,4,6-N-methyl-carbamoyl-3- (triiodo-2,4,4,6-N-methyl-acetamido-3-amino-5-benzoyl) -glycylamino-5-benzoic acid (compound 15 )
Radi se kao kod jedinjenja 1, ali polazeči od amina III i hlorida kiseline XXVIt works as with compound 1 but starting with amine III and acid chloride XXV
Primer 16Example 16
Dobijanje trijodo-2,4,6-N-metilakarbamoil-3-(trijodo-2,4,6-N-metil-acetamido-3-(trijodo-2,4,6N-metilkarbamoil-3-acetamido-5-benzoil)-glicilamino-5-benzoilj glicil-5-benzoeve kiseline (jedinjenje 16)Preparation of triodo-2,4,6-N-methylacarbamoyl-3- (triiodo-2,4,6-N-methyl-acetamido-3- (triiodo-2,4,6N-methylcarbamoyl-3-acetamido-5-benzoyl) ) -glycylamino-5-benzoyl glycyl-5-benzoic acid (compound 16)
a) trijodo-2,4,6-N-metil-karbamoil-3-[trijodo-2,a) triiodo-2,4,6-N-methyl-carbamoyl-3- [triiodo-2,
4.6- N-metil-acetamido-3-(trijodo-2,4,6-N-metilkarbamoil-3-amino-5-benzoil)-glicilamino-5-benzoilj glicil-amino-5-benzoeva kiselina (jedinjenje 16a).4.6-N-methyl-acetamido-3- (triiodo-2,4,6-N-methylcarbamoyl-3-amino-5-benzoyl) -glycylamino-5-benzoyl glycyl-amino-5-benzoic acid (compound 16a).
Radi se kao kod jedinjenja 1, ali polazeči od amina IX i hlorida kiseline XX.It works as with compound 1 but starting with amine IX and acid chloride XX.
b) Jedinjenje 16 se dobija acetilovanjem jedinjenja 16a.b) Compound 16 is obtained by acetylation of compound 16a.
Primer 1Example 1
Dobijanje trijodo-2,4,6-metil-karbamoil-3- [trijodo-2,4,6-N-metilacetamido-3-(trijodo-2,4,6-N-metil-karbamoil-3-N-metil-acetamido- 5 -benzoil) -glicilamino-5-benzoil3 -glicilamino-5-benzoeve kiseline (jedinjenje 17)Preparation of triiodo-2,4,6-methyl-carbamoyl-3- [triiodo-2,4,6-N-methylacetamido-3- (triiodo-2,4,6-N-methyl-carbamoyl-3-N-methyl -acetamido-5-benzoyl) -glycylamino-5-benzoyl3-glycylamino-5-benzoic acid (compound 17)
Radi se kao kod jedinjenja 1, ali polazeči od amina IX i hlorida kiseline XIX.It works as with compound 1 but starting from amine IX and acid chloride XIX.
Primer 18Example 18
Dobijanje trijodo-2,4»e-N-metilkarbamoil-9-(trijodo-2, 4, 6-N-metil-acetamido-3-benzoilgiicil)amino-5-benzoeve kiseline (jedinjenje 18)Preparation of triodo-2,4 ' -N-methylcarbamoyl- 9- (trido-2, 4, 6-N-methyl-acetamido-3-benzoylglycyl) amino-5-benzoic acid (compound 18)
Radi se kao kod jedinjenja 1, ali polazeči od amina III i hlorida kiseline XXI.It works as with compound 1 but starting from amine III and acid chloride XXI.
Primer 19Example 19
Dobijanje trijodo-2,4,6-(trijodo-2,4,6-N-metil-karbamoil-3-N-metilacetamido-5-benzoil) glicilamino-5-benzoeve kiseline (jedinjenje 19)Preparation of triiodo-2,4,6- (triiodo-2,4,6-N-methyl-carbamoyl-3-N-methylacetamido-5-benzoyl) glycylamino-5-benzoic acid (compound 19)
Radi se kao kod jedinjenja 1, ali polazeči od amina VI i hlorida kiseline XIX.It works as with compound 1 but starting from amine VI and acid chloride XIX.
Primer 20Example 20
Dobijanje trijodo-2,4,6-acetamido-3-(tri jodo-2,Preparation of triiodo-2,4,6-acetamido-3- (three iodo-2,
4,6-N-metil-acetamido-3-acetamido-5-benzoil) -glicilamino-5-benzoeve kiseline (jedinjenje 20)4,6-N-Methyl-acetamido-3-acetamido-5-benzoyl) -glycylamino-5-benzoic acid (compound 20)
a) Trijodo-2, 4, 6-acetamido-3-(trijodo-2, 4, 6-N-meti1-acetamido-3-amino-5-benzoil)-glicil-amino-5-benzoeva kiselina (jedinjenje 20a)a) Triiodo-2,4,4-acetamido-3- (triiodo-2,4,4-N-methyl-acetamido-3-amino-5-benzoyl) -glycyl-amino-5-benzoic acid (compound 20a)
Radi se kao kod jedinjenja 1, ali polazeči od amina VII i hlorida kiseline XXV.It works as with compound 1 but starting from amine VII and acid chloride XXV.
b) Jedinjenje 20 se dobija acetilovanjem jedinjenja 20ab) Compound 20 is obtained by acetylation of compound 20a
Primer 21Example 21
Dobijanje trijodo-2,4,6-(trijodo-2,4,6-N~metil-karbamoil-.3-acetamido-5-benzoil) -glicil-N-metilamino-3-benzoeve kiseline (jedinjenje 21)Preparation of triiodo-2,4,6- (triiodo-2,4,6-N ~ methyl-carbamoyl-3-acetamido-5-benzoyl) -glycyl-N-methylamino-3-benzoic acid (Compound 21)
a) Trijodo-2,4,6-(trijodo-2,4,6-N-metil-karbamoil-3-amino-5-benzoil)-glicil-N-metilamino-3-benzoeve kiseline (jedinjenje 21a).a) Triiodo-2,4,6- (triiodo-2,4,6-N-methyl-carbamoyl-3-amino-5-benzoyl) -glycyl-N-methylamino-3-benzoic acid (compound 21a).
Radi se kao kod jedinjenja 1, ali polazeči od amina X i hlorida kiseline XX.It works as with compound 1 but starting from amine X and acid chloride XX.
b) Jedinjenje 21 se dobija acetilovanjem jedinjenja 21a.b) Compound 21 is obtained by acetylation of compound 21a.
Primer 22Example 22
Dobij ar. je trijodo-2,4,6-( trijodo-2,4,6-N-me tilkarbamoil-3~N-metil-acetamido-5-benzoil)-gama aminobutirii-amino-3-benzoeve kiseline (jedinjenje 22)Get the ar. is tri-iodo-2,4,6- (triiodo-2,4,6-N-methylcarbamoyl-3 ~ N-methyl-acetamido-5-benzoyl) -aminobutyryl-amino-3-benzoic acid gamma (compound 22)
Radi se kao kod jedinjenja 1, ali polazeči od amina XI i hlorida kiseline XIX.It works as with compound 1 but starting from amine XI and acid chloride XIX.
Primer 23Example 23
Dobijanje trijodo-2,4,6-(trijcdo-2,4,6-N-metilkarbamoil-3-N-metilacetamido-S-benzoil)- gama aminopropionil-amino-3-benzoeve kiseline (jedinjenje 23)Preparation of triiodo-2,4,6- (tridido-2,4,6-N-methylcarbamoyl-3-N-methylacetamido-S-benzoyl) - gamma aminopropionyl-amino-3-benzoic acid (compound 23)
Radi se kao kod jedinjenja 1, ali polazeči od amina XII i hlorida kiseline XIX.It works as with compound 1 but starting from amine XII and acid chloride XIX.
Primer 24Example 24
Dobijanje trijodo-2,4,6-N-hidroksietil-karbamoil-3-(trijodo-2,4,6-N-metilkarbamoil-3-N-metil acetamido-5-benzoil)-gama-aminobutirilamino- 5 benzoeve kiseline (jedinjenje 24)Preparation of triodo-2,4,6-N-hydroxyethyl-carbamoyl-3- (trido-2,4,6-N-methylcarbamoyl-3-N-methyl acetamido-5-benzoyl)-gamma-aminobutyrylamino-5 benzoic acid ( compound 24)
Radi se kao kod jedinjenja 1, ali polazeči od amina XIV i hlorida kiseline XIX.It works as with compound 1 but starting from amine XIV and acid chloride XIX.
Primer 25Example 25
Dobijanje trijodo-2,4,6-acetamido-3-(trijodo-2,Preparation of triiodo-2,4,6-acetamido-3- (triiodo-2,
4.6- N-metil-karbamoil-3-N-metil-acetamido-5-benzoil)-glicilamino-5-benzoeve kiseline (jedinjenje 25)4.6- N-Methyl-carbamoyl-3-N-methyl-acetamido-5-benzoyl) -glycylamino-5-benzoic acid (compound 25)
Radi se kao kod jedinjenja 1, ali polazeči od amina VII i hlorida kiseline XIX.It works as with compound 1 but starting from amine VII and acid chloride XIX.
Primer 26Example 26
Dobijanje trijodo-2,4,6-N-metil-acetamido-3-(trijodo-2 , 4,6-N-metil-karbamoil-3-acetamido-5-benzoil)-glicilamino-5-benzoeva kiselina (jedinjenje 26) .Preparation of triodo-2,4,6-N-methyl-acetamido-3- (trido-2, 4,6-N-methyl-carbamoyl-3-acetamido-5-benzoyl) -glycylamino-5-benzoic acid (compound 26 ).
a) Trijodo-2,4,6-N-metil-acetamido-3-(trijodo-2, 4, 6-N-metil-karbamoil-3-amino-5-benzoil)-glicilaminc-5-benzoeva kiselina (jedinjenje 26a)a) Triiodo-2,4,6-N-methyl-acetamido-3- (triiodo-2,4, 6-N-methyl-carbamoyl-3-amino-5-benzoyl) -glycylamin-5-benzoic acid (compound 26a)
Radi se kao kod jedinjenja 1, ali polazeči od amina XIII i hlorida kiseline XX.It works as with compound 1 but starting from amine XIII and acid chloride XX.
b) Jedinjenje 26 se dobija acetilovanjem jedinjenja 26a.b) Compound 26 is obtained by acetylation of compound 26a.
Primer 27Example 27
Dobijanje trijodo-2,4,6-N-metil-karbamoil-3-(trijcdo-2,4,6-N-metil-karbamoil-3-amino- 5 -benzoil) -glicilamino-5-benzoeve kiseline (jedinjenje 27)Preparation of triiodo-2,4,6-N-methyl-carbamoyl-3- (tridido-2,4,6-N-methyl-carbamoyl-3-amino-5-benzoyl) -glycylamino-5-benzoic acid (compound 27 )
Radi se kao kod jedinjenja 1, ali polazeči od amina III i hlorida kiseline XX.It works as with compound 1 but starting with amine III and acid chloride XX.
Primer 28Example 28
Dobijanje trijodo-2,4,6-N-metil-karbamoil-3-[trijodo-2, 4,6-N-metilakarbamoil-3-(trijodo-2,4,6-N-metilkarbamoil-3-acetamido-5-benzoil)-glicilamino-5-benzoil] glicil-N-metilamino- 5 -benzove kiseline (jedinjenje 28)Preparation of triiodo-2,4,6-N-methyl-carbamoyl-3- [triiodo-2, 4,6-N-methylcarbamoyl-3- (triiodo-2,4,6-N-methylcarbamoyl-3-acetamido-5 -benzoyl) -glycylamino-5-benzoyl] glycyl-N-methylamino-5-benzoic acid (compound 28)
a) Trijodo-2,4,6-N-metil-karbamoil-3-ftrijodo-2,a) Triiodo-2,4,6-N-methyl-carbamoyl-3-fluorodo-2,
4.6- N-metilakarbamoil-?-(trijodo-2,4,6-N-metil karbamoil-3-amino-5-benzoil)-glicilamino-5-benzoilj glicil-N-metilamino - 5 -benzoeve kiseline (jedinjenje 28a).4.6- N-Methylcarbamoyl -? - (triiodo-2,4,6-N-methylcarbamoyl-3-amino-5-benzoyl) -glycylamino-5-benzoyl glycyl-N-methylamino-5-benzoic acid (compound 28a) .
Radi se kao kod jedinjenja 1, ali polazeči od amina XV i hlorida kiseline XX.It works as with compound 1 but starting from amine XV and acid chloride XX.
b) Jedinjenje 28 se dobija acetilovanjem jedinjenja 28a.b) Compound 28 is obtained by acetylation of compound 28a.
Primer 29Example 29
Dobijanje tri jodo-2,4,6, [[tri jodo-2,4,6-N-metilkarbamoil-3-(trijodo-2,4,6-N-metilkarbamoil-3-N-me ti iacetamido-5-benzoil) g lic ilamino-5-benzoil' glicilamino-3-benzoeve kiseline (jedinjenje 29) Radi se kao kod jedinjenja 1, ali polazeči od amina XVI i hlorida kiseline XIX.Preparation of three iodo-2,4,6, [[three iodo-2,4,6-N-methylcarbamoyl-3- (triiodo-2,4,6-N-methylcarbamoyl-3-N-methyl] acetamido-5- benzoyl) g licamylamino-5-benzoyl 'glycylamino-3-benzoic acid (compound 29) Worked as for compound 1 but starting from amine XVI and acid chloride XIX.
Primer 30Example 30
Dobijanje trijodo-2,4,-6-N-hidroksietil-karbamoil-3-[trijodo-2,4,6-N-metil-karbamoil-3(trijodo-2,4,6-N-metil-karbamoil-3-N-metilacetamido- 5 benzoil[ glicilainino-5-benzoeve kiseline (jedinjenje 30)Preparation of triiodo-2,4, -6-N-hydroxyethyl-carbamoyl-3- [triiodo-2,4,6-N-methyl-carbamoyl-3 (triiodo-2,4,6-N-methyl-carbamoyl-3 -N-methylacetamido-5 benzoyl [glycillainino-5-benzoic acid (compound 30)
Radi se kao kod jedinjenja 1, ali polazeči od amina XVII i hlorida kiseline XIX.It works as with compound 1 but starting from amine XVII and acid chloride XIX.
Primer 34Example 34
Dobijanje trijodo-2,4,6-(trijodo-2,4,6-N-metilkarbamoil-3-amino-5-benzoil)gliciiamino-3-benzove kiseline (jedinjenje 34)Preparation of triiodo-2,4,6- (triiodo-2,4,6-N-methylcarbamoyl-3-amino-5-benzoyl) glycylamino-3-benzoic acid (compound 34)
Radi se kao kod jedinjenja 1 , ali polazeči od amina VI i hlorida kiseline XX.It works as with compound 1 but starting from amine VI and acid chloride XX.
Primer 35Example 35
Dobijanje trijodo-2,4,6-N-metil-karbamoil-3-(trijodo-2 ,4,6-N-metil-karbamoil-3-glukonilamino-5-benzoil)-glicilamino-5-benzoeve kiseline (jedinjenje 35)Preparation of triiodo-2,4,6-N-methyl-carbamoyl-3- (triiodo-2,4,6-N-methyl-carbamoyl-3-gluconylamino-5-benzoyl) -glycylamino-5-benzoic acid (compound 35 )
a) Kondenzacijaa) Condensation
Suspenduje se 53,5 g (0,045 mola) jedinjenja 2? u 100 ml dimetilacetamida. Tome se doda 39 g hlorida pentaacetilglukonske kiseline (0,091 mola) dobijenog prema C.E. Braun i C.D.COOK: Organic Synthese, Vol. 41, s. 79-82. Suspenzija se meša 24 časa na sobnoj temperaturi. Reakcioni rastvor se, zatim, izlije u 500 ml vode. Tom prilikom se stvara smola koja kristališe posle 48 časova stajanja u hladnjaku.Suspended 53.5 g (0.045 mol) of compound 2? in 100 ml of dimethylacetamide. To this was added 39 g of pentaacetylgluconic acid chloride (0.091 mol) obtained according to C.E. Brown and C.D.COOK: Organic Synthese, Vol. 41, p. 79-82. The suspension was stirred for 24 hours at room temperature. The reaction solution is then poured into 500 ml of water. On this occasion, a resin is formed which crystallizes after 48 hours of standing in the refrigerator.
Cedi se i ispira vodom nekoliko puta.Drain and rinse several times with water.
HTS u eluentu 1HTS in eluent 1
Rf polaznog proizvoda 0,5Starting product Rf 0.5
Rf proizvoda kondenzacije 0,35Condensation product Rf 0.35
b) Dobijeni sirovi proizvod se rastvori u 300 ml amonijaka. Meša se preko noči na sobnoj temperaturi. Zatim se upari do suva, pod vakuumom i regeneriše u 125 ml vode.b) The crude product obtained is dissolved in 300 ml of ammonia. It is stirred overnight at room temperature. It was then evaporated to dryness under vacuum and regenerated in 125 ml of water.
Zakišeljava se sa hlorovodoničnom kiselinom razredjenom za polovinu.Acidify with hydrochloric acid by half.
Posle 48 časova stajanja u hladnjaku, talog se cedi i ispira vodom nekoliko puta. Posle sušenja se dobija 35 g proizvoda koji se ispira sa 350 ml etanola. Posle cedjenja i sušenja dobija se 30 g kiseline, što čini ukupan prinos od 49%. Kontrola čistoče:After standing in the refrigerator for 48 hours, the precipitate is drained and washed with water several times. After drying, 35 g of the product are washed, which is washed with 350 ml of ethanol. After straining and drying, 30 g of acid are obtained, accounting for a total yield of 49%. Cleanliness control:
HTS eluent 1: Rf 0,0 eluent 3: Rf 0,25 eluent 4: Rf 0,15HTS eluent 1: Rf 0.0 eluent 3: Rf 0.25 eluent 4: Rf 0.15
Dodavanjem u natrijum-karbonat: 98% Dodavanjem u jod: 100%Addition to Sodium Carbonate: 98% Addition to Iodine: 100%
Primer 36Example 36
Dobijanje trijodo-2,4,6-hidroksietil-karbamoil -3-(trijodo-2,4,6-N-metil-karbamoil-3-glukonil amino-5-benzoil)-glicilamino-5-benzoeve kiseline (jedinjenje 36)Preparation of triiodo-2,4,6-hydroxyethyl-carbamoyl -3- (triiodo-2,4,6-N-methyl-carbamoyl-3-gluconyl amino-5-benzoyl) -glycylamino-5-benzoic acid (compound 36)
Dobija se kao jedinjenje 35, ali polazeči od jedinjenja 3a.It is obtained as compound 35, but starting from compound 3a.
Primer 37Example 37
Dobijanje trijodo-2,4,6-(trijodo-2,4,6-N-meti1-acetamido-3-benzoil)-glicil-N-metilamino-benzoeve kiseline (jedinjenje 13, drugi način)Preparation of triiodo-2,4,6- (triiodo-2,4,6-N-methyl-acetamido-3-benzoyl) -glycyl-N-methylamino-benzoic acid (compound 13, second method)
146 g (0,13 mola) jedinjenja 12 rastvori se u 0,468 mola 4n natrijum-karbonata.146 g (0.13 mol) of compound 12 was dissolved in 0.468 mol 4n sodium carbonate.
Tome se dodaje, uz hladjenje, kap po kap, 0,338 mola metiljodida. Posle 16 časova mešanja na sobnoj temperaturi unosi se još 10% sredstava za metilovar.je i u 4N natrijum-karbonatu. Pošto se ostavi da reaguje tokom 48 časova, dolazi do taloženja u kiseloj sredini. Posle cedjenja, ispiranja i sušenja dobija se 118,5 g proizvoda. (Prinos od metilovanja je 72%) .To this was added, with cooling, 0.338 moles of methyl iodide. After 16 hours of stirring at room temperature, another 10% of the methylcarbonate is introduced into 4N sodium carbonate as well. After being allowed to react for 48 hours, precipitation in an acidic medium occurs. After straining, rinsing and drying, 118.5 g of product are obtained. (Methylation yield is 72%).
Kontrola čistoče:Cleanliness control:
1. HTS eluent 11. HTS eluent 1
Rf nemetilovanog proizvoda 0,^5 Rf metilovanog proizvoda 0,^8 i 0,8 HTS eluent 2Rf of methylated product 0, ^ 5 Rf of methylated product 0, ^ 8 and 0,8 HTS eluent 2
Rf nemetilovanog proizvoda 0,4Rf of unmethylated product 0,4
Rf metilovanog proizvoda 0,4 i 0,5 HTS eluent 4Rf of methylated product 0.4 and 0.5 HTS eluent 4
Rf nemetilovanog proizvoda 0,7 Rf metilovanog proizvoda 0,-1 i 0,75Rf of methylated product 0,7 Rf of methylated product 0, -1 and 0,75
Prečiščavanje:Purification:
Postiže se ekstrahcvanjem amonijumcve soli. Prinos je 80%.This is achieved by extracting the ammonium salt. The yield is 80%.
Dodavanjem u metilat 101%Adding to methylate 101%
Dodavanjem u natrijum-karbonat 97%Adding to sodium carbonate 97%
Primer 38Example 38
Dobijanje trijodo-2,4,6-N-metil-karbamoil-3-(trijodo-2,4,6-N-metil-karbamoil-3-acetamido-5-benzoil)-glicil-N-metilamino-5-benzove kiseline (jedinjenje 14, drugi način)Preparation of triodo-2,4,6-N-methyl-carbamoyl-3- (triiodo-2,4,6-N-methyl-carbamoyl-3-acetamido-5-benzoyl) -glycyl-N-methylamino-5-benzo acids (compound 14, second mode)
a) Dobijanje jedinjenja 14a na drugi način. Rastvori se 11,8 g (0,01 mola) proizvoda 27 u 15 ml 2N natrijum-karbonata (0,01 mola) i 4 ml acetona. Tome se dodaje, kap po kap. 2,8 ml metiljodida (0,04 mola). Posle 48 časova mešanja na sobnoj temperaturi, zakiseli se do pH 1 usled čega dolazi do taloženja. Posle cedjenja, ispiranja vodom, proizvod se ponovo rastvori. Zatim se pH podesi na ’-4 i propusti preko drvencg uglja. Filtrira se, taicži, cedi. Poslesušenja izoluje se 9 g proizvoda. Prinos je 75%. Kontrola čistoče:a) Preparation of compound 14a otherwise. Dissolve 11.8 g (0.01 mol) of product 27 in 15 ml of 2N sodium carbonate (0.0 1 mol) and 4 ml of acetone. Added to that, drop by drop. 2.8 ml of methyl iodide (0.04 mol). After stirring for 48 hours at room temperature, it was acidified to pH 1, resulting in precipitation. After straining, rinsing with water, the product is redissolved. The pH was then adjusted to '-4 and passed through charcoal. It's filtered, taichi, strained. After germination, 9 g of product is isolated. The yield is 75%. Cleanliness control:
HTS eluent 1HTS eluent 1
Rf polaznog proizvoda 0,5 Rf metilovanog proizvoda 0,6 Dodavanjem u metilat 98%Rf of starting product 0.5 Rf of methylated product 0.6 Adding to methylate 98%
b) Jedinjenje 14 se dobija ac^tilovanjem jedinjenja 14a.b) Compound 14 is obtained by acylating compound 14a.
Izvodi se na uobičajeni način pomoču CH^COCl rastvoren u DMAC. Prinos je 40%.It is carried out in the usual manner with the aid of CH 2 COCl dissolved in DMAC. The yield is 40%.
Primer 39Example 39
Dobijanje trijodo-2,4,6-N-metil-karbamoil-1-(tri j odo-2,4,6-N-me tilkarbamo i1-3-N-metilace tamido-5-benzoil)-gama-aminobutiril-N-metilamino-5-benzoeve kiseline (jedinjenje 37)Preparation of triiodo-2,4,6-N-methyl-carbamoyl- 1- (tri-odo-2,4,6-N-methylcarbamoyl) -1-3-N-methyl-tamido-5-benzoyl-gamma-aminobutyryl- N-methylamino-5-benzoic acid (compound 37)
Rastvori se 21 g (0,082 mola) jedinjenja 2 u 8,3 ml 5N natrijum-karbonata (0,0418 mola) i 12 ml vode. Tome se dodaje, kap po kap, 5,9 g metiljodida (0,0418 mola). Posle 24 časa mešanja na sobnoj temperaturi, zakiseli se do pH 1. Cedi se, ispira vodom i talog suši. Dobija se 20 g sirove kiseline.Dissolve 2 1 g (0.082 mol) of compound 2 in 8.3 ml of 5N sodium carbonate (0.0418 mol) and 12 ml of water. 5.9 g of methyl iodide (0.0418 moles) was added dropwise thereto. After stirring at room temperature for 24 hours, it was acidified to pH 1. It was drained, washed with water and the residue dried. 20 g of crude acid are obtained.
PrečiščavanjePurification
Postiže se kristalizacijom na toplo, u etanolu (20 g/40 ml) i pod refluksom tokom 3 časa. Posle cedjenja, proizvod se regeneriše u alkalnoj sredini i prepusti preko drvencg uglja. Posle taloženja sa kiselinom, cedi se, ispira vodom i osuši. Ukupr.o se izoluje 4,5 g proizvoda. Prinos je 20%.It was obtained by crystallization in warm, ethanol (20 g / 40 ml) and refluxed for 3 hours. After straining, the product is regenerated in an alkaline medium and passed over charcoal. After precipitation with acid, it is drained, washed with water and dried. A total of 4.5 g of product is isolated. The yield is 20%.
Kontrola čistoče:Cleanliness control:
HTS eluent 1HTS eluent 1
Rf nemetilovanog proizvoda 0,25 Rf metilovanog proizvoda 0,55Rf of non-methylated product 0,25 Rf of methylated product 0,55
HTS eluent 4HTS eluent 4
Rf nemetilovanog proizvoda 0,3 i 0,4 Rf metilovanog proizvoda 0,35, 0,30 i 0,25 Dodavanjem u natrijum-karbonat: 98% Dodavanjem u metilat: 98%Rf of non-methylated product 0,3 and 0,4 Rf of methylated product 0,35, 0,30 and 0,25 Addition to sodium carbonate: 98% Addition to methylate: 98%
Primer 40Example 40
Dobijanje trijodo-2,4,6-N-hidroksietil-karbamoil-3(trijodo-2,4,6-U-metil-karbamoil-3-acetami 15 do-benzoil)glicil-N-metilamino-5-benzoeve kiseline (jedinjenje 38)Preparation of triodo-2,4,6-N-hydroxyethyl-carbamoyl-3 (triiodo-2,4,6-U-methyl-carbamoyl-3-acetami 15 do-benzoyl) glycyl-N-methylamino-5-benzoic acid ( compound 38)
a) Dobijanje trijcdo-2,4,6-N-hidroksietil-karbamoil-3-(trijodo-2,4,6-N-metilkarbamoil-3-amino-5-benzoil)glicii-N-metilamino-5-benzoeve kiseline (jedinjenje 38a) .a) Preparation of trifluoro-2,4,6-N-hydroxyethyl-carbamoyl-3- (triiodo-2,4,6-N-methylcarbamoyl-3-amino-5-benzoyl) glycyl-N-methylamino-5-benzoic acid (compound 38a).
Dobija se kao i jedinjenje 14a, ali polazeči od jedinjenja 3a, metilovanjem.It is obtained as with compound 14a but starting from compound 3a by methylation.
b) Jedinjenje 38 se dobija acetilovanjem jedinjenja 38a na uobičajene načine. Prinos je 53%. Rf jedinjenja 38 i 38ab) Compound 38 is obtained by acetylation of compound 38a in the usual manner. The yield is 53%. Rf of compounds 38 and 38a
Eluent 1 Eluent 4Eluent 1 Eluent 4
0,15 0,25 i 0,30 (2 izomera)0.15 0.25 and 0.30 (2 isomers)
38a 0,25 0,32 i 0,40 (2 izomera)38a 0.25 0.32 and 0.40 (2 isomers)
Primer 41Example 41
Debijanje trijodo-2,4,6-N-metilkarbamoil-?-(trijcdo-2,4,6-N-metil-karbamoil-3-N-metilacetamido-5-benzoil)-beta-ammopropionil-amino-5-benzoeve kiseline (jedinjenje 39)Debut of triiodo-2,4,6-N-methylcarbamoyl -? - (trido-2,4,6-N-methyl-carbamoyl-3-N-methylacetamido-5-benzoyl) -beta-aminopropionyl-amino-5-benzoyl acids (compound 39)
Dobija se kao i jedinjenje 1, ali polazeči od amina XVIII i hlorida kiseline xix, pri čemu je o trajanje zagrevanja na temperaturi od 50 C 3 časa. Bruto prinos je 48%.It is obtained as well as compound 1, but starting from amine XVIII and acid chloride xix, where the heating time is at a temperature of 50 C for 3 hours. Gross yield is 48%.
Primer 42Example 42
Dobijanje trijodo-2,4,6-N-metil-karbamoi1-3-(trijodo-2,4 ,6-N-metil-karbamoil-3-N-metilacetami do-5-ben2oil)-beta-aminopropionil-N-metilamino -5-benzoeve kiseline (jedinjenje 40)Preparation of triiodo-2,4,6-N-methyl-carbamoyl-3- (triiodo-2,4,6-N-methyl-carbamoyl-3-N-methylacetamyl-5-benzoyl) -beta-aminopropionyl-N- methylamino -5-benzoic acid (compound 40)
Dobija.se metilovanjem jedinjenja 39.Obtained by methylation of compound 39.
Primer 43Example 43
Dobi jan je tri jodo-2,4,6-karbamoil-ž1- (tri jodo-2 ,Yo is three iodo-2,4,6-carbamoyl- 1 - (three iodo-2,
4.6- karbamoil-3-amino-5-benzoil)-glicil-amino-5-benzoeve kiseline (jedinjenje 41)4.6-Carbamoyl-3-amino-5-benzoyl) -glycyl-amino-5-benzoic acid (compound 41)
Radi se kao kod jedinjenja 1, ali polazeči od amina XXVIII i hlorida kiseline XXIX.It works as with compound 1 but starting from amine XXVIII and acid chloride XXIX.
Primer 44Example 44
Dobijanje trijodo-2,4,6-karbamoil-3-(trijcdo-2,Preparation of tridio-2,4,6-carbamoyl-3- (trid-2,
4.6- N-metil-karbamoil-3-amin.o-5-benzoil) -glicilamino-5-benzoeve kiseline (jedinjenje 42)4.6- N-Methyl-carbamoyl-3-amino-5-benzoyl) -glycylamino-5-benzoic acid (compound 42)
Radi se kao kod jedinjenja 1, ali polazeči od amina XXVIII i hlorida kiseline XX.It works as with compound 1 but starting with amine XXVIII and acid chloride XX.
Primer 45Example 45
Dobijanje trijodo-2,4,6-karbamoil-3-(trijodo-2,Preparation of triiodo-2,4,6-carbamoyl-3- (triiodo-2,
4.6- N-metil-karbamoil~3-acetamido-5-benzoil)-glicil-amino-5-benzoeve kiseline (jedinjenje 43) Jedinjenje 43 se dobija acetilovanjem jedinjenja 42.4.6- N-Methyl-carbamoyl ~ 3-acetamido-5-benzoyl) -glycyl-amino-5-benzoic acid (compound 43) Compound 43 is obtained by acetylation of compound 42.
Primer 46Example 46
Dobijanje trijodo-2,4,6-N-metilkarbamoil-3-(trijodo-2,4,6-karbamoil-.3-acetamido-5-benzoil) -glicil-N-metilamino-5-benzoeve kiseline (jedinjenjePreparation of triodo-2,4,6-N-methylcarbamoyl-3- (trido-2,4,6-carbamoyl-3-acetamido-5-benzoyl) -glycyl-N-methylamino-5-benzoic acid (compound
44)44)
a) Dobijanje trijodo-2,4,6-N-metilkarbamoil-3-(trijodo-2,4,6-karbamoil-3-amino-5-benzoil)-glicil-N-metilamino-5-benzoeve kiseline (jedinjenje 44a) .a) Preparation of triiodo-2,4,6-N-methylcarbamoyl-3- (triiodo-2,4,6-carbamoyl-3-amino-5-benzoyl) -glycyl-N-methylamino-5-benzoic acid (compound 44a ).
Radi se kao kod jedinjenja 1, ali polazeči od amina VIII i hlorida kiseline XXIX.It works as with Compound 1, but starting from amine VIII and acid chloride XXIX.
b) Jedinjenje. 44 se dobija acetilovanjem jedinjenja 44ab) The compound. 44 is obtained by acetylation of compound 44a
Primer 47Example 47
Dobijanje trijodo-2,4,6-N-metilkarbamoil-?-(trijodo-2,4,6-N-metilacetainido-3-acetamido-5-benzoil)-glicilamino-5-benzoeve kiseline (jedinjenjePreparation of triiodo-2,4,6-N-methylcarbamoyl -? - (triiodo-2,4,6-N-methylacetainido-3-acetamido-5-benzoyl) -glycylamino-5-benzoic acid (compound
45)45)
a) Dobijanje trijodo-2,4,6-N-metilkarbamoil-?-'' (trijodo-2,4,6-N-metilacetamido-3-amino-5-benzoil)-glicil-N-metilamino-5-benzoeve kiseline (jedinjenje 45a) .a) Preparation of triiodo-2,4,6-N-methylcarbamoyl -? - (triido-2,4,6-N-methylacetamido-3-amino-5-benzoyl) -glycyl-N-methylamino-5-benzoyl acids (compound 45a).
Radi se kao kod jedinjenja 1, ali polazeči od amina VIII i hlorida kiseline XXV.It works as with compound 1 but starting from amine VIII and acid chloride XXV.
b) Jedinjenje 45 se debija acetilovanjem jedinjenja 45a.b) Compound 45 is debuted by acetylation of compound 45a.
Primer 48Example 48
Dobijanje trijodo-2,4,6-N-metilkarbamoil-?-(trijodo-2 ,4 ,6-N-hidroksiet ilkarbamoil- 3 -acetamido5-ber,zoil) -glicil-N-metil-amino-5-benzoeve Kiseline (jedinjenje 46)Preparation of triiodo-2,4,6-N-methylcarbamoyl -? - (triiodo-2, 4, 6-N-hydroxyethyl ylcarbamoyl-3-acetamido5-ber, zoyl) -glycyl-N-methyl-amino-5-benzoic acid (compound 46)
a) Dobijanje trijodo-2,4,6-N-metilkarbamoil-?(trijodo-2,4,6-N-acetoksietilkarbamoil-3-diacetilamino-5-benzoil)-glicil-N-metil-amino-5-benzoeve kiseline (jedinjenje 46a).a) Preparation of triiodo-2,4,6-N-methylcarbamoyl -? (triiodo-2,4,6-N-acetoxyethylcarbamoyl-3-diacetylamino-5-benzoyl) -glycyl-N-methyl-amino-5-benzoic acid (compound 46a).
Radi se kao kod jedinjenja 1, ali polazeči od amina VIII i hlorida kiseline XXIII:It works as with Compound 1 but starting with amine VIII and acid chloride XXIII:
b) Jedinjenje 46 se dobija saponifikacijom jedinjenja 46a.b) Compound 46 is obtained by saponification of compound 46a.
Primer 49Example 49
Čebljanje trijodo-2,4,6-N-metilkarbamoil-3-Jtrijodo-2,4,6-M-metilkarbamoil-3-(bis-hidroksimetil-propionilamino)-5-benzoil-glicilJ -N-metilamino-5-benzoeve kiseline (jedinjenje 47)Beekeeping of triiodo-2,4,6-N-methylcarbamoyl-3-trifluoro-2,4,6-M-methylcarbamoyl-3- (bis-hydroxymethyl-propionylamino) -5-benzoyl-glycyl-N-methylamino-5-benzoyl acids (compound 47)
Radi se kao kod jedinjenja 35, ali polazeči, odnosno upotrebljavajuči jedinjenje 14a i hlorid bis-acetcksimetil-propicnske kiseline dobijen na isti način kao i hlorid pentaacetilglukonske kiseline.It works as with Compound 35, but starting or using Compound 14a and bis-acetylmethyl-propic acid chloride obtained in the same way as pentaacetylgluconic acid chloride.
Primer 50Example 50
Dobijenje trijodo-2,4,6-N-metilkarbamoil-3-(trijcdo-2, 4,6,-N-metilkarbamoil-3-glukonilamino-5benzoil)-glicil-N-metilamino-5-benzoeve kiseline (jedinjenje 48)Preparation of triodo-2,4,6-N-methylcarbamoyl-3- (triddo-2, 4,6, -N-methylcarbamoyl-3-gluconylamino-5benzoyl) -glycyl-N-methylamino-5-benzoic acid (compound 48)
Radi se kao kod jedinjenja 35, ali polazeči od jedinjenja 14a.It works as with compound 35 but starting from compound 14a.
Primer 51Example 51
Dobijanje trijodo-2,4,6-acetamido-3-(trijodo-2,Preparation of triiodo-2,4,6-acetamido-3- (triiodo-2,
4,6-N-metilkarbamoil-3-acetamido-5-benzoil)-glicil-N-metilaminc-5-benzoev« kiseline (jedinjenje 49)4,6-N-Methylcarbamoyl-3-acetamido-5-benzoyl) -glycyl-N-methylamino-5-benzoic acid (Compound 49)
a) Dobijanje trijodo-2,4,6-acetamido-3-(trijodo-2, 4,6-N-metilkarbamoil-3-amino-5-benzoil)-glicil-amino-5-benzoeve kiseline (jedinjenje 49a). Radi se kao kod jedinjenja 1, ali polazeči od trijodo-2,4,6-acetamido-3-aminoacetilamino-5-benzoeve kiseline VII i hlorida kiseline XX.a) Preparation of triiodo-2,4,6-acetamido-3- (triiodo-2,4,6-N-methylcarbamoyl-3-amino-5-benzoyl) -glycyl-amino-5-benzoic acid (compound 49a). It works as with Compound 1 but starting from triiodo-2,4,6-acetamido-3-aminoacetylamino-5-benzoic acid VII and acid chloride XX.
b) Dobijanje trijodo-2,4,6-acetamido-3-(trijodo-2,4,6-N-met.ilkarbamoil-3-amino-5-benzoil) -glicil-N-metilamino-5-benzoeve kiseline (jedinjenje 49b) .b) Preparation of triiodo-2,4,6-acetamido-3- (triiodo-2,4,6-N-methylcarbamoyl-3-amino-5-benzoyl) -glycyl-N-methylamino-5-benzoic acid ( compound 49b).
Jedinjenje dobljeno pod a) se metiluje u metil-jodid.The compound obtained under a) is methylated to methyl iodide.
c) Dobijanje trijodo-2,4,6-acetamido-3-(trijodo-2, 4,6-N-metilkarbamoil-?-acetamido-5-benzoil)-glicil-N-metilamino-5-benzoeve kiseline (Postiže se acetilovanjem jedinjenja pod b).c) Preparation of triiodo-2,4,6-acetamido-3- (triiodo-2,4,4-N-methylcarbamoyl -? - acetamido-5-benzoyl) -glycyl-N-methylamino-5-benzoic acid (To be achieved by acetylating the compound under b).
U Tablici V su prikazani podaci koji se odnose na dobijanje jedinjenja formule II i dobljena jedinjenja, dok su formule dobljenih jedinjenja prikazane u Tablici Vi.Table V shows data relating to the preparation of compounds of formula II and the compounds obtained, while the formulas of the compounds obtained are shown in Table Vi.
Tablica VTable V
Juii.-JoRje ; olaccl antnJuii.-JoRje; olaccl antn
rroko I Ja pioka I __2i_ profcu JI iarroko I I pioka I __2i_ profcu JI ia
Λ_iv.Iv_iv.
prsLo IprsLo I
G c olacni Ciutc nr a ela- Γτίηοβ - «cetil*. ft/ u eluants 1 felortd princa aata 1 vanj» ♦ uepoaLfl. poei* oaveGiilMaSiUfi_Metla _ \fc»on»_ __5_< ,____5_6_ _ t _Π£_H* o·»_ <U_Q.?S____G c olacni Ciutc nr a ela- Γτίηοβ - «cetil *. ft / u eluants 1 felortd prince aata 1 out »♦ uepoaLfl. poei * oaveGiilMaSiUfi_Metla _ \ fc »on» _ __5_ <, ____ 5_6_ _ t _Π £ _H * o · »_ <U_Q.?S ____
XX 52% 0.2 54> o.l _&__:_XX 52% 0.2 54> o.l _ & __: _
XXiI Kile U 0,2 70/ -aalc kondea« 0.1XXiI Kile U 0.2 70 / -aalc conde «0.1
- ____ clovas _ fcaoile _ . „- ____ clovas _ fcaoile _. "
ΧλΙΙΙ Nilc 1*-0,2$ -ljc laclovfcA 0*15 _£i2»£D____ ' _ΧλΙΙΙ Nilc 1 * -0.2 $ -ljc laclovfcA 0 * 15 _ £ i2 »£ D ____ '_
Λίχ_e;« c.20_ i_ m Tti o,2t 76; i 0,1?Λίχ_e; «c.20_ i_ m Tti o, 2t 76; i 0,1?
r^čtLč-vaiija - oiizt.cj· u clacntBr ^ čtLč-vaiija - oiizt.cj · u clacntB
-ačlp Irlnoc B,QB ’ o; -a J _a__d_io n i2 » lil;!_C2‘/ ICC» le·» 110¾ ¢.1¾-lp Irlnoc B, QB 'o; -a J _a__d_io n i2 »lil;! _ C2 '/ ICC» le · »110¾ ¢ .1¾
Λ __._Ό*_leo« 9.¾ ?9.c·« 0.25_ x;4' ivj. ioiy 5;» 53,5» o.iΛ __._ Ό * _leo "9.¾? 9.c ·" 0.25_ x; 4 'ivj. ioiy 5; »53.5» oi
7(5 ϊόΰ ί(·Λ &<w <ζϊ7 (5 ϊόΰ ί (· Λ & <w <ζϊ
Evdl 17» Wf 97» 9£Jt oTSEvdl 17 »Wf 97» 9 £ Jt oTS
Ul.gpaAUl.gpaA
ΝΒ,Ι__44« ion« W/._0,1 m:4 521 1021 95,5? 99.8» o,« :·ί α «l» »Ota 4ΝΒ, Ι__44 «ion« W /._ 0.1 m: 4 521 1021 95.5? 99.8 "o,": · ί α «l» »Ota 4
U žal L M ^iiC.4Unfortunately L M ^ iiC.4
L,1 « «Ji «ata 2 o,l O «tl cr.ta 2L, 1 «« Ji «ata 2 o, l O« tl cr.ta 2
0,15 1 0Λ0.15 1 0Λ
pivko Vili Xx 144beer Willie Xx 144
97% 0,597% 0.5
3β% >c« ίβροιύΠΙο- Mic prc£16tav*a . ol4· 0,63β%> c «ίβροιύΠΙο- Mic prc £ 16tav * a. ol4 · 0.6
0,2 0.52 1 o,55 ',d preko VIU XX 14«0.2 0.52 1 o, 55 ', d over VIU XX 14 «
97% 0,5 Pcele clukar.llova leale slukoui- Ulic iculcT-a n ja 30/. l«T*aJ· 0,55,97% 0,5 Bees clukar.llova leale slukoui- Street iculcT a n i 30 /. l «T * aJ · 0.55,
... ------- i-— posla «apor.iri_ Molla O__... ------- i-— jobs «apor.iri_ Molla O__
0,0 0,2 1 0.25 (1) Pode tilstnlltnelle a 500 ral «tentl» pod rollakaon* (2) Vogla Urlotalltaolle u etanola (97 a a I50 ni pod rofluksoi' (5) Poele fcrUMUx--*cllo a itanola (450 e u 500 ml pod ruflak» ttoa) .0.0 0.2 1 0.25 (1) Fits tilstnlltnelle a 500 acre «tentl» under rollakaon * (2) Urlotalltaolle corners in ethanol (97 aa I50 not under rofluxoi '(5) Poele fcrUMUx - * cllo a itanola (450 eu 500 ml under ruflak »ttoa).
(4) Γχ-οίχίοηο taloierde raatvoio 1 dloutilfonamldu pcooiu voda.(4) Γχ-οίχίοηο taloierde raatvoio 1 dloutilfonamldu pcooiu water.
(5) Taljenje raotvora 1 nettnoiu penoču ltopropll-elkohola, (7) lepirende m etsnoloa.(5) Melting of solution 1 nettnoi foam of ltopropll-alcohol, (7) leprosy m etsnoloa.
TABLICA ΥΙTABLE ΥΙ
COOH hoch2ch2nhciCOOH hoch 2 ch 2 nhci
J s/ JJ s / J
HHC0CH2NHC0HHC0CH 2 NHC0
CONHCH,CONHCH,
JJ
NCOCH, i iNCOCH, i i
J CH3J CH 3
3b3b
COOHCOOH
J > 'V JJ> 'In J
CONHCH, ^2 3CONHCH, ^ 2 3
H0CH2CH2HNCiH0CH 2 CH 2 HNCi
ONHCH,ONHCH,
NHCOCHgNHCO^· ^NHCOCHjNHCOCHgNHCO ^ · ^ NHCOCHj
COOH J ToTCOOH J ToT
HOCH2CH2HNCO-*\zx>' NHCOCHpNHCOHOCH 2 CH 2 HNCO - * \ z x > 'NHCOCHpNHCO
COOHCOOH
TofTof
CONHCH,CONHCH,
COCH,COCH,
J · J /OOCH^J · J / OOCH ^
HOCHgCHgHNCO^^/^HHCOCHgNHCO ‘ ch3nhcoHOCHgCHgHNCO ^^ / ^ HHCOCHgNHCO 'ch 3 nhco
COOH CONHCHjCHgOHCOOH CONHCHjCHgOH
J ' < J J/V o i ! oTJ '<J J / V o i! oT
NHCO (CH 2) 3 ΝΗΟΟ'^χ/4'NHO CCHjNHCO (CH 2 ) 3 ΝΗΟΟ '^ χ / 4 ' NHO CCHj
cooh conhch2ch2oocch3 cooh conhch 2 ch 2 oocch 3
J>/\z J J J “ I°I 1°ϊJ> / \ z J J J “I ° I 1 ° ϊ
CH3NHC0zKxyX^NHC0(CH2)3irHC0 NCOCH3 CH 3 NHC0 zK x y X ^ NHC0 (CH 2 ) 3 irHC0 NCOCH 3
Γ J CCCHjCC J CCCHj
H0CH2CH2NHCH0CH 2 CH 2 NHC
hcoch2nhcohcoch 2 nhco
H0CH2CH2NHCH0CH 2 CH 2 NHC
CHjNHCCHjNHC
COOHCOOH
CHjNHCOCHjNHCO
NHCOCH,NHCOCH,
NCOCH, sbccch2nhcoNCOCH, sbccch 2 nhco
NCOCH,NCOCH,
COKHCH2CH2OHCOKHCH 2 CH 2 OH
NHCO(CH2)3NHCONHCO (CH 2 ) 3 NHCO
CONHCH2CH2OOCCH5 CONHCH 2 CH 2 OOCCH 5
NHCO(CH2)3NHCO NCOCHjNHCO (CH 2 ) 3 NHCO NCOCHj
J CH,J CH,
NHCO(CH2)5-HHCONHCO (CH 2 ) 5 -HHCO
COOHCOOH
COOHCOOH
14»14 »
CH^NHCOCH ^ NHCO
NHC0CH2NHC0NHC0CH 2 NHC0
-NH,-NH,
COOHCOOH
1* ΎοΥ ! o1 * ΎοΥ! o
CH^NHCO >\ .XnHCOCH2NHCOCH ^ NHCO> \ .XnHCOCH 2 NHCO
CHjNCOCH,CHjNCOCH,
NHCOCHjNHCO'NHCOCHjNHCO '
CONHCH, 1 r'·.CONHCH, 1 r '·.
-'J-'J
Xhcoch,Xhcoch,
1ČB1ЧБ
COOH j γ'ο'Ύ J COOH j γ'ο'Ύ J
CH3NCOCH3 CH 3 NCOCH 3
CONHCH,CONHCH,
CH.NHCCT^/^ NHCOCH,NHCOCH.NHCCT ^ / ^ NHCOCH, NHCO
CHjNHCOCHjNHCO
NECOCH2NHCONECOCH 2 NHCO
NHC0CH2NHC0NHC0CH 2 NHC0
CH,NCOCH, J 1 JCH, NCOCH, J 1 J
NHCOCHgNHCO·NHCOCHgNHCO ·
NH,NH,
CONHCH,CONHCH,
YJ Y J
II
Ajcoch,Ajcoch,
I iI i
C H, laC H, la
COOHCOOH
CH,C0H(X\. NHCOCH-NHCO ^x^XNC0CH, 3 r 2 I I 5 CH, C0H (X \. NHCOCH-NHCO ^ x ^ XNC0CH, 3 r 2 II 5
J J CHjJ J CHj
COOH ' L COOH ' L
RH, t 2RH, t 2
20a20a
CH^COHNHHcocH2:raco A^.-^ncocHjCH ^ COHNHHcocH 2 : raco A ^ .- ^ ncocHj
COOHCOOH
CONHCH,CONHCH,
SiCOCHjNHCO J ch3 SiCOCHjNHCO J ch 3
J 'KCOCH,J 'KCOCH,
COOHCOOH
λ.λ.
CONHCHCONHCH
21a * T r~\ f o21a * T r ~ \ f o
RC0CH2NHC0 - x NH, CH,RC0CH 2 NHC0 - x NH, CH,
COOH hoch2ch2nhcoCOOH hoch 2 ch 2 nhco
co(ch2)3nh»co (ch 2 ) 3 nh »
CONHCHCONHCH
CONHCH,CONHCH,
COOH 1' θ XCOOH 1 'θ X
CH3 CONH -^\/BHCOCH2 NHCO ' NCOCH, I i 3CH 3 CONH - ^ \ / BHCOCH 2 NHCO 'NCOCH, I and 3
J CK,J CK,
COOH ! C i iCOOH! C i i
CONHCH,CONHCH,
26a ch,co;26a ch, co;
>C°k> C ° k
NHCOCH2NHCO NHCOCHjNHCOCH 2 NHCO NHCOCHj
CH,CON5 CH.CH, CON 5 CH.
ONHCH nhcoch2nhcoONHCH nhcoch 2 nhco
OOHOOH
CHjNHCO' nhcoch2nhcoCHjNHCO 'nhcoch 2 nhco
CONHCH,CONHCH,
COOHCOOH
CONHCH,CONHCH,
CONHCH,CONHCH,
'NHCOCHjNHCO'NHCOCHjNHCO
CH,NHCC^\ /^NCOCH-NHCO 3 r i z CH, NHCC ^ \ / ^ NCOCH-NHCO 3 ri z
J CH,J CH,
HCOCH,HCOCH,
CONHCH,CONHCH,
CONHCH,CONHCH,
COOHCOOH
NCOCH., NHCO I 2 ch3 nhcoch2nhco NH2 NCOCH., NHCO I 2 ch 3 nhcoch 2 nhco NH 2
NHCOCHjNHCOCONHCH,NHCOCHjNHCOCONHCH,
CONHCH, 'NHCOSH2NHCCCONHCH, 'NHCOSH 2 NHCC
COCH,COCH,
J CH3J CH 3
COOHCOOH
J x J ' n pONHCEj J X/ JJ x J 'n pONHCEj J X / J
C ONHCH 3 C ONHCH 3
J'.J '.
: r-.: r-.
nhcoch2nhco • - 'NCOCHjnhcoch 2 nhco • - 'NCOCHj
J CH3 J CH 3
COOHCOOH
J Χ-ΧJ Χ-Χ
CONHCH,CONHCH,
CH,tiHCOz'. . xNHCCCH NHCO X. ·ΉΗΟθ(0ΗΟΗ)ςΗCH, tiHCO z '. . x NHCCCH NHCO X. · ΉΗΟθ (0ΗΟΗ) ςΗ
J tJ t
COOHCOOH
H0CH2CH2HNC0'H0CH 2 CH 2 HNC0 '
Λ χΧχ·' JΛ χΧχ · 'J
Ί O ;Ί O;
nhcoch2nhconhcoch 2 nhco
CONHCH,CONHCH,
X· c NHCO(CHOH)5HX · c NHCO (CHOH) 5 H
CONHCH,CONHCH,
COOHCOOH
J. ' JJ. 'J
CHjNHCOCHjNHCO
NCO(CH2)jNHCI C H, orJ NCO (CH 2 ) jNHCI CH, or J
COCH,COCH,
J CH3J CH 3
HOCH2CH2HNCOHOCH 2 CH 2 HNCO
HOCH2CH2HNCOHOCH 2 CH 2 HNCO
NC0CH2NHC0NC0CH 2 NHC0
JONHCH,JONHCH,
ncoch2nhco 'ΧγΧ'ra2 J CH3 jncoch 2 nhco 'ΧγΧ'ra 2 J CH 3 j
COOHCOOH
CHjNHCOCHjNHCO
CHjNHCO-CHjNHCO-
CONHCH·CONHCH ·
nhgo(ch2)2nhconhgo (ch 2 ) 2 nhco
CONHCH, < χ.·>CONHCH, <χ. ·>
i o 1and o 1
NHCO(CH2)2NHCO XXX N-COCH3 CHj J CHjNHCO (CH 2 ) 2 NHCO XXX N-COCH 3 CHj J CHj
COOHCOOH
CCNHCH, nh2co -\^.^nhcoch2nhccCCNHCH, nh 2 co - \ ^. ^ Nhcoch 2 nhcc
'rof a2CO '^^SHCOCHjSHCO -^/TiHCOCBj'rof a 2 CO' ^^ SHCOCHjSHCO - ^ / TiHCOCBj
COOH jAjCOOH jAj
CCNH,CCNH,
CH^ilHCOz\/^N-COCH2NHCO/\z' NHj J CH, \ (44a)CH ^ ilHCO z \ / ^ N-COCH 2 NHCO / \ z 'NHj J CH, \ (44a)
CHCH
COOHCOOH
CONH, · .'J (44) ^NHCO / fl N-COCHgNHCO ζγ HHCOCHjCONH, · .'J (44) ^ NHCO / fl N-COCHgNHCO ζ γ HHCOCHj
J CH,J CH,
CHjNHCOCHjNHCO
COOH J /P J io:COOH J / P J io:
CH,-N-COCH, J /\/J (45»)CH, -N-COCH, J / \ / J (45 »)
N-COCHgNHCO J *H3N-COCHgNHCO J * H 3
NH,NH,
COOHCOOH
Jv' ^J iO ch5-n-coch3 Jv '^ J iO ch 5 -n-coch 3
J pYjJ pYj
O;O;
(45)(45)
CHjNHC'CHjNHC '
N-COCH,NHCO I 4N-COCH, NHCO I 4
CH,CH,
NHCOCH,NHCOCH,
COOH CONHCH,CH„OCOCH, i i 2 2 3 j/\/JCOOH CONHCH, CH „OCOCH, i i 2 2 3 j / \ / J
N-COCH,NHCO Λ. Λ CH, ‘ . COCH,N-COCH, NHCO Λ. 'CH,'. COCH,
CHjNHCCHjNHC
N-COCH,NHCO in 2 N-COCH, NHCO and 2
2ONHCH2CH2OH (46« (46)2ONHCH 2 CH 2 OH (46 «(46)
COOHCOOH
Jx/vJ !rvJx / vJ! Rv
CONHCH,CONHCH,
J/v JJ / v J
OjOh
CH,NHCO'V1 N-COCH,NHCO Λ·-/ NH, (14«)CH, NHCO'V 1 N-COCH, NHCO Λ · - / NH, (14 «)
T1 i J CH,T 1 and J CH,
COOHCOOH
JJ
CONHCH,CONHCH,
J\/' z JJ \ / 'with J
CHjNHCO /CHjNHCO /
CH.OHCH.OH
Pi 1 Pi 1
N-COCHgNHCO A/ NHCO-CH-CH^N-COCHgNHCO A / NHCO-CH-CH2
CH,CH,
CH2OH (47)CH 2 OH (47)
(48)(48)
D. Pobijanje injekcionih rastvoraD. Solution of injection solutions
Injekcioni rastvori farmaceutskog kvaliteta izradjuju se u obliku soli metilglukamina iii natrijuma i sadrže 28, 38 iii 48g joda na 100 ml (tzv. rastvori sa 28, 38 i 48%-nim jodom).Pharmaceutical grade injectable solutions are made in the form of methylglucamine or sodium salts and contain 28, 38 or 48g of iodine per 100 ml (so-called 28, 38 and 48% iodine solutions).
Posle punjenja u ampule u atmosferi azota, proizvod se steriliše 2agrevanjem na 120 C tokom 20 minuta.After being charged to ampoules under a nitrogen atmosphere, the product is sterilized by 2 heating at 120 C for 20 minutes.
U Tablici VII prikazani su podaci, odnosno rezultati merenja viskoziteta rastvora soli metilgukamina od 2 % na 3 C. Ovi rezultati pokazuju da jedinjenja formule II, suprotr.o cd onoga što se može očekivati, imaju, kada se rastvore, relativno slab viskozitet.Table VII presents the data, that is, the results of measuring the viscosity of a solution of methylgucamine salts of 2% at 3 C. These results show that the compounds of formula II, in contrast to cd of what can be expected, have, when dissolved, relatively low viscosity.
Tablica VIITable VII
Jedinjenje oThe compound o
Viskozitet na C u centipoazimaViscosity at C in centipoises
5,45.4
6,566.56
5,^25, ^ 2
5,25.2
5,55.5
5,85.8
5,25.2
U Tablici VIII dati su rezultati merenja osmolarnosti.The results of osmolarity measurements are given in Table VIII.
Merenje osmolarnostiOsmolarity measurement
Veličina osmolarnosti dobija se ekstrapolacijom cifara koje se dobijaju sukcesivnim razredjivanjem rastvora od 28% i 38% joda.The magnitude of the osmolarity is obtained by extrapolating the figures obtained by successively diluting the solution with 28% and 38% iodine.
Osmolarnost se odredjuje pomocu FISKE-ovog osmometra model 230/D/330 D.Osmolarity is determined using the FISKE osmometer model 230 / D / 330 D.
Ovaj aparat daje ove veličine u miosmolovima na kilogram rastvora. Aparat radi na principu krioskopije.This apparatus gives these sizes in myosmol per kilogram of solution. The device works on the principle of cryoscopy.
Merenja se izvode u rastvorima od 28%-nog joda.Measurements are made in solutions of 28% iodine.
Tablica VIIITable VIII
a * 1410 * a, b i c su sledeči proizvodi na koje b * 1390 c * 950a * 1410 * a, b and c are the following products to which b * 1390 c * 950
a. Trijodo-2,4,6-N-metilkarbamoil-3-acetamido-5-benzoeva kiselina b: Trijodo-2,4,6-N-hidroksietil-karbamoil-3 acetamido-5-benzoeva kiselina c: Adipoildiimido-5,51-bis-(trijodo-2,4,6-N metilizoftalaminska)a. Triiodo-2,4,6-N-methylcarbamoyl-3-acetamido-5-benzoic acid b: Triiodo-2,4,6-N-hydroxyethyl-carbamoyl-3 acetamido-5-benzoic acid c: Adipoildiimido-5,5 1- bis- (triiodo-2,4,6-N methylisophthalamine)
Očigledno da jedinjenja formule II imaju, kada su u obliku soli metilglukamina, osmolarnost koja je manja od osmolarnosti proizvoda na koje se poziva.The compounds of formula II are obviously, when in the form of methylglucamine salts, have an osmolarity that is less than the osmolarity of the product referred to.
Slede rezultati upcrednih toksikoloških i farmakoloških proučavanja.The results of advanced toxicological and pharmacological studies follow.
Odredjivanje akutne toksičnostiDetermination of acute toxicity
Toksičnost u miševa pri intravenskom davanju Ovo odredjivanje davanjem sredstava u venu vrši se na miševima IOPS, soja OFI, švajcarske pasmine.Toxicity to mice by intravenous administration This determination by vein delivery is performed on IOPS mice, an OFI strain, of a Swiss breed.
Svaka doza se ubrizgava grupi od 10 miševa od kojih je 5 mužjaka i 5 ženki.Each dose is injected into a group of 10 mice, of which 5 are males and 5 females.
Injekcije se daju ručno, u vratnu venu, brzinom od 2 ml/min.Injections are given manually, in the neck vein, at a rate of 2 ml / min.
Smrtnost se utvrdjuje 24 časa posle davanja injekcije.Mortality is determined 24 hours after the injection.
Ispitivanje eliminisanja putem žuči, odnosno bilijarnog trakta u mačkeTests for elimination via the bile or the biliary tract in cats
Ispitivanje se izvodi na odraslim mačkama, mužjacima iii ženkama, telesne mase cd 3 do 4 kg.The test is performed on adult cats, males or females weighing cd 3 to 4 kg.
Proizvod se daje intravenski u dozi od 0,10 g/kg joda, u unutrašnju venu noge. Eliminacija proizvoda se prati radiološkom kontrolom.The product is administered intravenously at a dose of 0.10 g / kg iodine, into the internal vein of the leg. Elimination of the product is monitored by radiological control.
Snimci koji prikazuju žučnu kesicu i mehur uzimaju se u sledečim vremenskim razmacima:Shots showing gallbladder and bladder are taken at the following intervals:
minuta, 3 čas, 2 časa, 3 časa, 4 časa, 5 časova i 6 časova.minutes, 3 hours, 2 hours, 3 hours, 4 hours, 5 hours and 6 hours.
Dejstvo na širenje bedrene arterijeThe effect on the enlargement of the femoral artery
Ispitivanje se izvodi na psima nečiste rase, mužjacima iii ženkama, od 7 do 12 kg telesne mase, anesteziranim Nembutalom.The test is performed on dogs of impure race, males or females, 7 to 12 kg body weight, anesthetized with Nembutal.
Nembutal se upotrebljava u količini od 30 mg/kg uz prethodno davar.ie leka Vetranouil (ukuona intiavenska injekcija od 2,5 mg); respiracija je spontana.Nembutal is used in an amount of 30 mg / kg with the prior administration of Vetranouil (a 2.5 mg intravenous injection); respiration is spontaneous.
Ispitivanja varijacija širenja arterije izvode se na nivou desne i leve bedrene arterije pomocu elektromagnetnog senzora.Tests for the variation of artery expansion are performed at the level of the right and left femoral arteries using an electromagnetic sensor.
Injekcije se daju kolateralno od bedrene arterije, discedentno od senzora, pomocu katetera koji je postavljen retrogradno, da ne bi došlo do izlivanja krvi.Injections are given collaterally from the femoral artery, dissenting from the sensor, using a catheter that is placed retrograde to prevent blood leakage.
Injekcije su konstantne zapremine od 1,5 ml i daju se u trajanju 3 do 5 s.The injections are of a constant volume of 1.5 ml and are administered over a period of 3 to 5 s.
Takodje se daje i ista zapremina izotoničnog rastvora natrijumhlorida.The same volume of isotonic sodium chloride solution is also given.
Dobijeni rezultati su prikazani u Tablici IX.The results obtained are shown in Table IX.
Tablica IXTable IX
0, 10 g/kg J0, 10 g / kg J
28% i 38%28% and 38%
NaOn
7,57.5
b: Trijodo-2,4,6-N-hidroksietil-karbamoil- 3 -acetamido-5-benzoeva kiselinab: Triiodo-2,4,6-N-hydroxyethyl-carbamoyl-3-acetamido-5-benzoic acid
C; Adipiildiimino-5,5'bis(trijodo-2,4,6-N-metilizoftalna) kiselina d; Trijodo-2, 4, 6-bis(acetamido)-3,5-benzoeva kiselina e: Adipoildiimino-3,3'-bis(trijodo-2,4,6-ami no-benzoeva) kiselinaC; Adipyldiimino-5,5'bis (triiodo-2,4,6-N-methylisophthalic) acid d; Triiodo-2, 4, 6-bis (acetamido) -3,5-benzoic acid is: Adipoildiimino-3,3'-bis (triiodo-2,4,6-amino-benzoic acid)
Prema torne, jedinjenja formule II mogu se upotrebljavati kao kontrastna sredstva za radiološke svrhe.According to the invention, the compounds of formula II can be used as contrast agents for radiological purposes.
Glavna namena ovih jedinjenja je u urografiji, angiografiji, holangiografiji i mielografiji.The main purpose of these compounds is in urography, angiography, cholangiography and myelography.
Na jprver.stveni je farmaceutske oblike kontrastnih sredstava čine vodeni rastvori soli jedinjenja formule II.The pharmaceutical formulations of contrast agents, for example, are aqueous solutions of salts of the compounds of formula II.
Vodeni rastvori prvenstveno sadrže od 5 do 100 g soli na 100 ml, a količina ovih rastvora koja se injektira može varirati od 5 do 1000 ml.Aqueous solutions preferably contain from 5 to 100 g of salt per 100 ml, and the amount of these injectable solutions can vary from 5 to 1000 ml.
οΐξΐκ^5 !-CO(0Hj) NHοΐξΐκ ^ 5 ! -CO (0Hj) NH
Kao najbolji način za privrednu upotrebu prijavljenog pronalaska, podnosioc prijave navodi sledeči;As the best way to commercially use the claimed invention, the applicant states the following;
Dobijanje trijodo-2,4,6-N-hidroksietilkarbamoil-3-trijcdo-2,4,6-N-metilkarbamoil-?-N-metil- N acetilamir.o-5-benzoil-glicilamino-5-benzoeve kiselinePreparation of triiodo-2,4,6-N-hydroxyethylcarbamoyl-3-triido-2,4,6-N-methylcarbamoyl -? - N-methyl-N acetylamir.-5-benzoyl-glycylamino-5-benzoic acid
a) Kondenzacija:a) Condensation:
165 g (0,25 mola) trijodo-2,4,6-N-hidroksi<:,tilkarbamoil-3-aminc-acetamido-5-benzoeve kiseline se suspenduje u smeši dimetilacetamida (250 ml) i trietilamina (58,50 g). U ovu suspenziju se doda 161 g hlorida trijodc-2,4,6-N-metil-karbamoil-3-N-metil-N-acetilamino-5-benzoeve kiseline o (0,25 mola). Smeša se snažno meša na 50 C tokom 6 časova. Pomcču hrcmatografije na tankom sloju (HTS) dokazano je da ostaje manje od >% polaznog proizvoda.165 g (0.25 mol) of triiodo-2,4,6-N-hydroxy , tilcarbamoyl-3-amin-acetamido-5-benzoic acid was suspended in a mixture of dimethylacetamide (250 ml) and triethylamine (58.50 g ). To this suspension was added 16 1 g of triiodic-2,4,6-N-methyl-carbamoyl-3-N-methyl-N-acetylamino-5-benzoic acid o (0.25 mol) chloride. The mixture was stirred vigorously at 50 C for 6 hours. Thin-layer microscopy (HTS) has shown that less than>% of the starting product remains.
Rastvor se izlije u 1240 ml vode. Stvara se neznatan talog koji se očedi. U filtrat se doda hlorovodonična kiselina do jako kiselog pH, a zatim se očedi i ispira sa vodom i osuši u susnici na 80 C. Debija se 186 g sirovog proizvoda, što čini prinos cd 61%.The solution is poured into 1240 ml of water. An insignificant precipitate is created, which becomes clear. Hydrochloric acid is added to the filtrate to a very acidic pH, then it is washed and washed with water and dried at 80 C. The 186 g of crude product is debuted, making a cd yield of 61%.
Kontrola čistoče:Cleanliness control:
HTS elu<=nt 1HTS elu <= nt 1
1. Rf polaznog amina 0,05 Ri' hlorida kiseline 0,801. Rf of starting amine 0.05 R1 'acid chloride 0.80
Rf proizvoda kondenzacije 0,15The condensation product Rf is 0.15
2. Čistoča proizvoda posle dodavanja natrijum-karbonata 95%2. Purity of product after addition of sodium carbonate 95%
Čisteča proizvoda posle dodavanja metilata 98,5%Product purity after the addition of methylate 98.5%
Čistoča proizvoda posle dodavanja joda 9Ί%Product purity after iodine addition 9 Ί %
b) prečiščevanje:b) purification:
Postiže se kristalizacijam na toplo u etanolu na 95qC. 186 g se suspenduje u 400 ml etanola na 95 C i drži se pod refluksom, posle 6 časova dolazi do petpunog rastvaranja, a zatim se proizvod kristališe. Ukupno zagrevanje traje 36 časova. Zatim se ostavi da se ohladi.It is obtained by crystallisation by warming in ethanol at 95 q C. 186 g is suspended in 400 ml of ethanol at 95 C and kept under reflux, after 5 hours, a five-hour dissolution occurs, and then the product crystallizes. Total warm-up takes 36 hours. It is then allowed to cool.
Posle cedjenja, vlažan proizvod se rastvara u 400 ml vode i natrijum karbonata. pH se. podesi na 4-5 pomoču sirčetne kiseline i propust.i se dva puta kroz drveni ugalj. filtrira se, a zatim zakiseli do jako kiselog pH sa koncentrovanom hlorovodoničnom kiselinom.After straining, the wet product is dissolved in 400 ml of water and sodium carbonate. pH se. adjust to 4-5 with acetic acid and pass through twice through charcoal. it is filtered and then acidified to a strongly acidic pH with concentrated hydrochloric acid.
Posle filtriranja, ispiranja sa vodom, cedjenja i sušenja, dobija se 115 g čistog proizvoda, što čini prinos od 62%.Filtration, washing with water, straining and drying gave 115 g of pure product, yielding 62%.
Kontrola čistoče:Cleanliness control:
1. HTS kao kod koncentracije1. HTS as in concentration
2. Čistoča proizvoda posle dodavanja natrijum-karbonata 101%2. Product purity after addition of sodium carbonate 101%
Čistoča proizvoda posle dodavanja u metilat 98,5%Product purity after addition to methylate 98,5%
Čistoča proizvoda posle dodavanja joda 100,5%Product purity after iodine addition 100,5%
Claims (2)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB24169/74A GB1488903A (en) | 1974-05-31 | 1974-05-31 | X-ray contrast media |
| YU1368/75A YU39658B (en) | 1974-05-31 | 1975-05-28 | Process for obtaining 2,4,6-nitriiodo-5-(2,4,6-triiodo-5-amino-benzoyl)-amino-alkyl-carbonl-amino-benzoic acids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI7511368A8 true SI7511368A8 (en) | 1994-12-31 |
Family
ID=26256963
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI7511368A SI7511368A8 (en) | 1974-05-31 | 1975-05-28 | Process for obtaining 2,4,6-nitriiodo-5-(2,4,6-triiodo-5-amino-benzoyl)-amino-alkyl- carbonyl-amino-benzoic acids |
Country Status (1)
| Country | Link |
|---|---|
| SI (1) | SI7511368A8 (en) |
-
1975
- 1975-05-28 SI SI7511368A patent/SI7511368A8/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI65988B (en) | SAOSOM ROENTGENKONTRASTMELEL ANVAENDBARA IODBENSENDERIVAT | |
| KR840001963B1 (en) | Process for the preparation of 1-aryl-2-acylamido-3-fluoro-1-propanols | |
| US4005188A (en) | X-ray contrast media | |
| SU753358A3 (en) | Method of preparing peptides or their salts | |
| DE69122831T2 (en) | S- (LOW FATTY ACIDS) SUBSTITUTED GLUTATHION DERIVATIVES | |
| FR2511871A1 (en) | PROCESS FOR INCREASING THE TOLERANCE OF OPACIFYING PRODUCTS AND OPACIFYING PRODUCTS THUS OBTAINED | |
| US3622616A (en) | New benzoic acid derivatives | |
| USRE32268E (en) | Therapeutic composition and method of therapeutically treating warm blooded animals therewith | |
| US4065554A (en) | X-ray contrast media | |
| DE69208400T2 (en) | Mono- and bis-alkylaminoanthracyclines | |
| SI7511368A8 (en) | Process for obtaining 2,4,6-nitriiodo-5-(2,4,6-triiodo-5-amino-benzoyl)-amino-alkyl- carbonyl-amino-benzoic acids | |
| JPH01153667A (en) | Substituted dicarboxylic acid-bis (3, 5-dicarbamoyl-2, 4, 6-triiodo-anilide, its production and x-ray contrast medium containing said compound | |
| DE2329745C2 (en) | Medicines against viruses of the Picorna group | |
| EP0267179A2 (en) | Cystin compounds, their preparation and their use | |
| US3290366A (en) | 5-amino-nu-alkyl-2, 4, 6-triiodoisophthalamic acid derivatives | |
| DE1695744C3 (en) | N- [δ- (purinylthio) valeryl] amino acids and derivatives | |
| JPS6054960B2 (en) | Anti-inflammatory septacidin analogs | |
| FR2512014A1 (en) | BROMINATED COMPOUNDS FOR USE IN OPACIFYING PRODUCTS | |
| DD283804A5 (en) | METHOD FOR PRODUCING NEW NON-SPECIAL, IODIED TRIIODBENZEN COMPOUNDS | |
| FI67841C (en) | SAOSOM ROENTGENKONSTRASTMELEL ANVAENDBARA IODBENSENDERIVAT | |
| Heath et al. | 489. 2-Mercaptoglyoxalines. Part II. Application of the mannich reaction. Protection of the thiol group | |
| KR970004044B1 (en) | Aromatic acid intermediates | |
| US3538076A (en) | Acyl derivatives of erythromycylamine | |
| NL8202658A (en) | ESTERS OF 2-THENOYLMERCAPTOPROPIONYLGLYCIN WITH SUBSTITUTED HYDROXYBENEES, METHODS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE ESTERS. | |
| DD204476A5 (en) | METHOD FOR PRODUCING HALOGEN-CONTAINING, AROMATIC CARBONIC ACID AMIDES |